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ABSTRACT 
 
The composition, absorption, metabolism, and excretion of gallic acid, 
monogalloyl glucose, and gallotannins in mango (Mangifera indica L.) pulp were 
investigated. Each galloyl derivative was hypothesized to have a different rate of 
absorption, and their concentrations were compared in the pulp of five mango varieties. 
The cultivar Ataulfo was found to have the highest concentration of monogalloyl 
glucose and gallotannins while the cultivar Kent had the lowest. Enzymatic hydrolysis of 
gallotannins with tannase led to the characterization of six digalloyl glucoses and five 
trigalloyl glucoses that have the potential to be formed in the colon following gallotannin 
consumption. 
 The bioaccessibility of galloyl derivatives was evaluated in both homogenized 
mango pulp and 0.65 mm3 cubes following in vitro digestion conditions. Monogalloyl 
glucose was found to be bioaccessible in both homogenized and cubed mango pulp. 
However, cubed mango pulp had a significantly higher amount of gallotannins still 
bound to the fruit following digestion. Gallic acid bioaccessibility significantly increased 
following digestion in both homogenized and cubed mango pulp, likely from hydrolysis 
of gallotannins. Additionally, for the first time, the absorption of monogalloyl glucose 
and gallic acid was investigated in both Caco-2 monolayer transport models and a 
porcine pharmacokinetic model with no significant differences found in their absorption 
or ability to produce phase II metabolites. 
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 A method to extract free gallic acid and its metabolites using sodium dodecyl 
sulfate from plasma was developed, and the method extracted significantly (p<0.05) 
more pyrogallol, gallic acid, and their phase II metabolites compared to conventional 
methods that rely on solvent extractions or use of solid phase extraction. The method 
was reproducible and precise across three standard concentrations from 50 to 500 μg/L. 
The method is hypothesized to be more effective due to the ability of sodium dodecyl 
sulfate to denature proteins and inhibit polyphenol-protein interactions. 
The pharmacokinetics of mango gallic acid and galloyl glycosides were 
evaluated in subjects who consumed mango daily for 42 days, and a significant (p<0.05) 
increase was observed in the urinary excretion of 4-O-methylgallic acid-3-O-sulfate, 
pyrogallol-O-sulfate, methylpyrogallol-O-sulfate, and catechol-O-sulfate. However, this 
same significant increase in metabolism was not observed in plasma concentrations. It 
was proposed that repetitive mango consumption created changes in the gut microbiota 
population increasing concentration of gallic acid and pyrogallol in the colon, but due to 
how quickly gallic acid is excreted from the body no accumulation in plasma was 
observed.  
 
 iv 
 
DEDICATION 
 
For my mother, Tammy, who always told me, you get out of life what you put into it. 
 
 
 v 
 
ACKNOWLEDGEMENTS 
 
I would first like to thank Dr. Stephen Talcott, my committee chair. Without all 
your advice, mentoring, and friendship none of this research would have been possible. I 
have been truly blessed to have had the opportunity to work alongside you these past few 
years. To Dr. Susanne Talcott, my co-chair, thank you for all your help and support 
along this journey, and a special thank you for allowing me to be the teaching assistant 
for the study abroad course in Italy. It was the trip of a lifetime for me, and I was very 
grateful for the opportunity. Thanks also goes to my other committee members Dr. 
Nancy Turner and Dr. Arul Jayaraman who were helpful in the design of my 
experiments with publications in mind. 
I want to give a special thank you to Kimmy who was such a great mentor when I 
first joined the lab as an undergraduate. You played a big part in my decision to go to 
graduate school, and helped give me the skills I needed to successfully complete my 
PhD. I would like to also thank my lab mates who were working on their PhDs alongside 
me, Hyemee, Paula, Maritza, Matt, and Chuo. It was great having y’all as coworkers and 
friends, and thank you for always lending a hand if I needed help with my experiments. 
To my siblings, Dylan, Clinton, and Zoe, it has been great having y’all close by 
while I was in graduate school. I have loved each and every time we have all gotten to be 
together. To my roommates Brandon, Chadley, and Wes thank you for always having an 
open ear to listen to my research problems. 
 vi 
 
I would also like to thank all the nurses who assisted in the daily mango 
consumption clinical trial, and especially Cathy who would always be willing to make 
time for a study day. To my Dad and Laurie, thank you for all of your trips up to College 
Station and all the meals that came with them. To Joe, thanks for always giving a 
helping hand with any car troubles during my tenure at A&M. Finally, my deepest 
thanks goes to my mother, Tammy, who has sacrificed so much for all her children. This 
dissertation would not have been possible without all your love and support. 
  
 vii 
 
CONTRIBUTORS AND FUNDING SOURCES 
 
 The work for this dissertation was supervised by a dissertation committee 
chaired by Dr. Stephen Talcott, co-chaired by Dr. Susanne Talcott, and with support 
from Dr. Nancy Turner of the Department of Nutrition and Food Science and Professor 
Arul Jayaraman of Chemical Engineering. The clinical trials were performed at the 
facilities of Dr. Nicholaas Duetz with assistance from his staff. The clinical trials and 
Caco-2 monolayer studies were performed with assistance from Hyemee Kim.  
This dissertation was funded fully by the National Mango Board (Orlando, FL). 
The National Mango Board sponsors research and promotion of domestic and imported 
mangos. 
 viii 
 
TABLE OF CONTENTS 
 
 Page 
ABSTRACT .......................................................................................................................ii 
DEDICATION .................................................................................................................. iv 
ACKNOWLEDGEMENTS ............................................................................................... v 
CONTRIBUTORS AND FUNDING SOURCES ............................................................vii 
TABLE OF CONTENTS ............................................................................................... viii 
LIST OF FIGURES ............................................................................................................ x 
LIST OF TABLES ......................................................................................................... xiii 
CHAPTER I  INTRODUCTION ....................................................................................... 1 
CHAPTER II  LITERATURE REVIEW ........................................................................... 4 
2.1 The Role of Fruits and Vegetables in Health ........................................................... 4 
2.2 Polyphenolics: Synthesis, Nomenclature, and Properties ........................................ 5 
2.3 Mango History and Composition ........................................................................... 10 
2.4 Polyphenol Absorption, Metabolism, Distribution, and Excretion ........................ 13 
CHAPTER III  QUANTIFICATION OF GALLIC ACID AND GALLOYL 
GLYCOSIDES IN FIVE MANGO CULTIVARS AND THE 
CHARACTERIZATION OF TANNASE HYDROLYSIS PRODUCTS ....................... 23 
3.1 Introduction ............................................................................................................ 23 
3.2 Materials and Methods ........................................................................................... 26 
3.3 Results and Discussion ........................................................................................... 29 
3.4 Conclusions ............................................................................................................ 42 
CHAPTER IV  IN VITRO BIOACCESSIBILITY AND IN VIVO ABSORPTION 
OF MANGO GALLIC ACID AND GALLOYL GLYCOSIDES ................................... 43 
4.1 Introduction ............................................................................................................ 43 
4.2 Materials and Methods ........................................................................................... 44 
4.3 Results and Discussion ........................................................................................... 51 
4.4 Conclusions ............................................................................................................ 65 
 ix 
 
CHAPTER V  A NOVEL PROTEIN PRECIPITATION METHOD FOR THE 
RECOVERY OF GALLIC ACID METABOLITES IN PLASMA ................................. 66 
5.1 Introduction ............................................................................................................ 66 
5.2 Materials and Methods ........................................................................................... 68 
5.3 Results and Discussion ........................................................................................... 73 
5.4 Conclusions ............................................................................................................ 85 
CHAPTER VI  DAILY CONSUMPTION OF MANGO CV. ATAULFO FOR 42 
DAYS AND ITS INFLUENCE ON THE METABOLISM AND EXCRETION OF 
GALLIC ACID, GALLOYL GLYCOSIDES, AND GALLOTANNINS ....................... 86 
6.1 Introduction ............................................................................................................ 86 
6.2 Materials and Methods ........................................................................................... 88 
6.3 Results and Discussion ........................................................................................... 92 
6.4 Conclusions .......................................................................................................... 106 
CHAPTER VII  SUMMARY AND CONCLUSIONS .................................................. 107 
REFERENCES ............................................................................................................... 110 
APPENDIX .................................................................................................................... 136 
 
 x 
 
LIST OF FIGURES 
 Page 
Figure 1. Sequential synthesis of gallic acid to pentagalloylglucose [34]. ........................ 7 
Figure 2.  Parent structures of polyphenols subclasses [37]. ............................................. 8 
Figure 3. Polyphenol absorption, metabolism, distribution, and excretion ...................... 14 
Figure 4.  The current proposed mechanisms on the ADME of gallic acid and galloyl 
glycosides ......................................................................................................... 18 
Figure 5. Concentrations (mg/kg) of gallic acid (GA), ester-monogalloyl glucose 
(Ester-MGG), and ether-monogalloyl glucose (Ether-MGG) across five 
mango cultivars. ................................................................................................ 31 
Figure 6. Chemical structures for gallic acid (A), ester-monogalloyl glucose (B), and 
ether-monogalloyl glucose (C). ........................................................................ 32 
Figure 7. Chemical structures for trigalloyl glucose (A), tetragalloyl glucose (B), 
pentagalloyl glucose (C), and decagalloyl glucose. .......................................... 33 
Figure 8. Composition of gallotannins ranging in degree of polymerization from 
trigalloyl glucose (3GG) to decagalloyl glucose (10GG) across five mango 
cultivars. ............................................................................................................ 35 
Figure 9. Hydrolysis of pentagalloyl glucose (5GG) and subsequent formation of 
tetragalloyl glucose (4GG), trigalloyl glucose (3GG), digalloyl glucose 
(2GG) following 2 h incubation with tannase at 10-3 U/mL. ............................ 37 
Figure 10. Chromatogram of five digalloyl glucoses and six trigalloyl glucoses at 280 
nm (A) and extracted ion chromatograms at m/z 483.2 (B), and 635.2 (C) 
generated from hydrolysis of pentagalloyl glucose following 2 h incubation 
with tannase at 10-3 U/mL. ................................................................................ 38 
Figure 11. Hydrolysis of monogalloyl glucose (MGG) and subsequent formation of 
gallic acid (GA) following 4 h incubation with tannase at 10-3 U/mL. ............ 40 
Figure 12. Hydrolysis of gallotannin isolate ranging in composition from tetragalloyl 
glucose (4GG) to undecagalloyl glucose (11GG) following 2 h incubation 
with tannase at 10-3 U/mL. ................................................................................ 41 
Figure 13. Bioaccessibility of monogalloyl glucose in (A) mango extract, (B) 
homogenized mango pulp, and (C) cubed mango and free gallic acid in (D) 
 xi 
 
mango extract, (E) homogenized mango pulp, and (F) cubed mango under 
in vitro digestion conditions at 37 °C, pH 2.0 for 2 h and pH 7.1 for 8 h, 
with digestive enzymes. .................................................................................... 54 
Figure 14. Stability of gallic acid and monogalloyl glucose following in vitro 
digestion at 37 oC pH 2.0 for 2 h and pH 7.1 for 8 h, with digestive 
enzymes. ........................................................................................................... 55 
Figure 15. Gallic acid, monogalloyl glucose, and gallotannins bound to cellular 
matrices of homogenized mango pulp and cubed mango following in vitro 
digestion at 37 °C pH 2.0 for 2 h and pH 7.1 for 8 h with digestive enzymes. . 57 
Figure 16. Area under the curve (AUC) for the metabolites gallic acid, 4-O-
methylgallic acid, and 4-O-methylgallic acid-3-O-sulfate after oral 
administration of gallic acid and monogalloyl glucose determined in a 
porcine model. .................................................................................................. 64 
Figure 17. Comparison in extraction recoveries of pyrogallol (PG), gallic acid (GA), 
4-O-methylgallic acid (MG), and ethyl gallate (EG) using precipitation with 
acetonitrile (ACN), SDS protein precipitation method (SDS), and solid 
phase extraction using Waters HLB cartridges (HLB) all at 500 μg/L. 
Different letters for each analyte denote a significant difference in recovery 
based on extraction method (p< 0.05). ............................................................. 77 
Figure 18. Pharmacokinetics of 4-O-methylgallic acid (MG), 4-O-methylgallic acid-
3-O-sulfate (MGS), following tentative characterization and semi-
quantification in human plasma after consumption of 400 g of mango pulp 
(cv. Ataulfo) in healthy volunteers. Data represent the average and standard 
error of the mean (n=10). .................................................................................. 80 
Figure 19. Pharmacokinetics of pyrogallol-O-sulfate (PGS), methylpyrogallol-O-
sulfate (MPGS), and catechol-O-sulfate (CS) following tentative 
characterization and semi-quantification in human plasma after 
consumption of 400 g of mango pulp (cv. Ataulfo) in healthy volunteers. 
Data represent the average and standard error of the mean (n=10). ................. 81 
Figure 20. Tentative chemical structures of phase II metabolites following 
consumption of gallic acid, galloyl glycosides, and gallotannins sourced 
from 400 g of mango cv. (Ataulfo) pulp. .......................................................... 93 
Figure 21. The sum of urinary excretion in mg for the metabolites 4-O-methylgallic 
acid-3-O-sulfate (MGS), pyrogallol-O-sulfate (PGS), two isomers of 
methylpyrogallol-O-sulfate (MPGS), and catechol-O-sulfate (CS) after 
consumption of 400 g of mango cv. Ataulfo for Days 1 and 42 in the (A) 
Lean and (C) Obese Cohorts who consumed mango daily for 42 days and 
 xii 
 
the (B) Control Cohort who consumed mango only on Days 1 and 42. A (*) 
designates a significant difference between Days 1 and 42 for the respective 
metabolite. ........................................................................................................ 96 
Figure 22. Cumulative excretion in mg of the galloyl metabolites: 4-O-methylgallic 
acid-3-O-sulfate (MGS), pyrogallol-O-sulfate (PGS), two isomers of 
methylpyrogallol-O-sulfate (MPGS), and catechol-O-sulfate (CS) in the 
Lean Cohort following daily consumption of 400 g of mango cv. Ataulfo 
for 42 days on Days 1 and 42. .......................................................................... 99 
Figure 23. Sum of the area under the curve (AUC) for all galloyl metabolites in the 
plasma of subjects who consumed mango only on Days 1 and 42 (Control) 
and those who consumed mango daily for 42 days, on Days 1 and 42 (Lean 
and Obese). A (*) designates a significant difference between Days 1 and 
42 for the respective cohort. ........................................................................... 102 
Figure 24. Plasma concentrations of 4-O-methylgallic acid-3-O-sulfate in human 
plasma on Days 1 and 42 following consumption of 400 g of mango (cv. 
Ataulfo) pulp in the Lean Cohort who consumed mango daily for 42 days. 
A (*) designates a significant difference between Days 1 and 42. ................. 104 
 
 
 xiii 
 
LIST OF TABLES 
 Page 
 
Table 1.  Plasma recoveries for gallic acid by use of solid phase and solvent 
extraction. ......................................................................................................... 21 
Table 2. Mass to Charge Ratios (m/z) and λmax for gallic acid, galloyl glycosides, and 
gallotannins. ...................................................................................................... 30 
Table 3. Characterization and concentrations (mg/kg) of galloyl derivatives in mango 
(cv. Ataulfo) pulp. ............................................................................................. 52 
Table 4. Transport of 50 μg/mL gallic acid, monogalloyl glucose, and pyrogallol 
across the apical to basolateral side of Caco-2 monolayers over 2 h. .............. 59 
Table 5. Pharmacokinetic parameters for gallic acid and monogalloyl glucose 
following oral and IV administration in a 10 h pilot porcine absorption 
study. ................................................................................................................. 61 
Table 6. Extraction recoveries, matrix effect, and inter-day precision of gallic acid 
metabolites (pyrogallol, gallic acid, 4-O-methylgallic acid, and ethyl 
gallate) in human plasma using sodium dodecyl sulfate at three 
concentrations (50, 250, and 500 µg/L). ........................................................... 74 
Table 7. Characterization and pharmacokinetic parameters of gallic acid metabolites 
following human consumption of 400 g of mango pulp (cv. Ataulfo). ............ 79 
Table 8. Comparison of gallic acid and pyrogallol phase II metabolite plasma 
concentrations from pooled plasma using SDS protein precipitation method 
(SDS), acetonitrile protein precipitation (ACN), and solid phase extraction 
with HLB chemistry (HLB). ............................................................................. 84 
Table 9. Metabolites characterized and quantified in the plasma and urine of subjects 
who consumed 400 g of mango cv. Ataulfo pulp daily for 42 days. ................ 94 
Table 10. Area Under the Curve (AUC) from 0 to 8 h of phase II metabolites sourced 
from gallic acid and galloyl glycosides following daily consumption of 
mango cv. Ataulfo pulp for 42 days in Lean and Obese Cohorts, and 
compared against subjects who consumed mango only on days 1 and 42, 
Control Cohort. ............................................................................................... 101 
 
 
 1 
 
CHAPTER I  
INTRODUCTION  
 
Mango (Mangifera indica L.) is perhaps the most popular fruit in the world. 
Historically enjoyed for its unique flavor and sweet taste, mango has also been used to 
treat asthma, dysentery, sinus troubles, and even dandruff [1, 2]. Mangos, while native to 
South Asia, are now grown in tropical and subtropical regions all over the globe with 
cultivars available for consumption throughout the year in most developed countries [3]. 
For example, the United States has seen a rise in mango popularity over the past decade, 
and mango can now be found in grocery stores all over the country. Central and South 
America supply the majority of fruit that is consumed in the US, and mango is enjoyed 
in all stages of ripeness in a wide variety of products. The recent growth in mango’s 
popularity has given attention to the potential health benefits regarding mango 
consumption with specific regards to its fiber, vitamin C, and polyphenolic content. 
Polyphenols are a group of plant secondary metabolites that are acclaimed for 
their potential role in the overall benefits of fruit and vegetable consumption [4-8]. All 
edible parts of the mango (peel, flesh, and seed kernel) have been found to contain 
galloyl derived polyphenols, which include gallic acid, mono-galloyl glucoses, and 
gallotannins ranging in degrees of polymerization from 4 to 12 galloyl substitutions [9-
13]. The anti-inflammatory and anti-cancer activities of polyphenol extracts derived 
from mango flesh, peel, and skin have been reported in vitro [5, 6, 14, 15]. However, 
these studies did not take into consideration the role metabolism may have on 
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polyphenol consumption. The human super organism treats polyphenolics as 
xenobiotics, non-nutritive, non-endogenous compounds; which upon absorption in the 
GI tract polyphenolics will be conjugated with methyl, sulfur, or glucuronide functional 
groups by epithelial or hepatic enzymes. Polyphenols not absorbed in the small intestine 
will continue to the colon where they can be catabolized by the enzymes produced by the 
microbiota that reside there creating metabolites that were not initially present in the 
fruit itself. This makes the conclusions from prior in vitro work on polyphenol isolates 
inadequate in supporting the hypotheses that fruit and vegetable polyphenols positively 
contribute to human health as the polyphenolics found in fruit are unlikely to be the form 
exerting anti-inflammatory and anti-cancer activity in vivo. Additional studies are 
needed to characterize what metabolites are found after consumption of polyphenols as 
well as their concentration in plasma and tissues to allow for a deeper understanding on 
the mechanisms behind polyphenols and health. 
Mangos’ current global popularity and wide range of galloyl derivatives make it 
a practical and relevant medium for studying gallic acid metabolism. Gallic acid has 
been shown to possess both anti-cancer and anti-inflammatory activity in vitro [16], and 
if its metabolites display these activities as well it will aide in strengthening the 
hypothesis that polyphenols contribute to the health benefits of fruits and vegetables. 
The objectives of this work were as follows: 
1. Quantify the gallic acid and galloyl glycoside content in five different U.S. 
mango cultivars, and characterize the effects of tannase on gallotannin 
hydrolysis. 
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2. Investigate and compare the absorption and metabolism of gallic acid and 
monogalloyl glucose through in vitro digestion and in vivo porcine models. 
3. Develop a more efficient method for the extraction of gallic acid metabolites 
from human plasma.  
4. Quantify the changes in gallic acid, galloyl glycoside, and gallotannin 
metabolism in subjects who consume mango daily for 42 days. 
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CHAPTER II  
LITERATURE REVIEW  
 
2.1 The Role of Fruits and Vegetables in Health 
The consumption of fruits and vegetables has long been associated with health 
and longevity, and fruit and vegetable intake has been reported to reduce the risks of 
cancer and cardiovascular diseases in a number of meta-analyses [17-22].  Geographic 
regions such as the Mediterranean which includes Spain, Southern Italy, and Greece 
have lifestyles where fruits and vegetables are a predominate portion of their traditional 
diets and have historically had some of the highest rates of human life expectancy and 
lowest incidences of cardiovascular disease and cancer around the world [23]. 
Despite the suggested benefits of fruit and vegetable intake the United States 
reported no increase in their average consumption (3.43 servings of fruits and vegetables 
per day) in US adults from 1990 – 2010 [24, 25], and during the same time period the 
United States has observed an obesity epidemic [26]. This obesity epidemic has sparked 
educational movements for healthier lifestyles such as the national leadership’s ‘Lets 
Move’ campaign, Healthy People 2020, and the USDA’s 2010 MyPlate which 
recommends that half the plate of each meal should consist of fruits and vegetables [27]. 
While these campaigns have helped raise awareness for healthier lifestyles, a recent 
investigation reported a decrease in fruits and vegetables consumption from 2009 - 2014 
[28].  
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Despite the reports that have associated fruit and vegetable consumption with 
reduced risk of cancer and cardiovascular diseases the exact mechanisms behind the 
benefits of fruits and vegetables are still unclear, but they have mainly been attributed to 
their phytochemical content. Phytochemicals, or compounds that naturally occur in 
plants, can be anything from vitamins, minerals, fatty acids, proteins, and dietary fiber. 
With such a wide range of different phytochemicals in all the fruits and vegetables it has 
been difficult for researchers to pinpoint the mechanism behind their benefits. Among 
the non-nutrient phytochemicals, polyphenolics are a group of compounds that have 
achieved notoriety in the biomedical and food sciences due to their in vitro antioxidant 
capacity, and are believed to be an important class of bioefficacious compounds present 
in fruits and vegetables.   
2.2 Polyphenolics: Synthesis, Nomenclature, and Properties 
2.2.1 Plant Metabolism, Chemical Structure, and Physical Properties 
Polyphenols are a class of phytochemicals in higher plants, and are well known 
for their prevalence in the human diet and potential health benefits [29]. A polyphenol is 
defined by its chemical composition of a benzene ring that contains multiple hydroxyl 
groups covalently linked. Polyphenols serve several roles in plants including providing 
color, antimicrobial properties, protection from reactive oxygen species, and protection 
from herbivores and insects [30]. 
Plant biosynthesis of polyphenols and other aromatic compounds such as the 
essential amino acids phenylalanine, tyrosine, and tryptophan begin with the precursor 
erythrose-4-phosphate and phosphoenolpyruvate as intermediates of glycolysis. Through 
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a series of enzymatic reactions known as the shikimic acid pathway these precursors 
produce shikimic acid. Shikimic acid then produces hydroxybenzoic acids through 
dehydrogenation to form gallic acid, or under a different path produce phenylalanine or 
tyrosine [31]. After production of phenylalanine, direct synthesis of other polyphenols 
can begin through the phenylpropanoid pathway, a series of enzymatic reactions which 
involve deamination proceeded by production of cinnamic acids, and the further 
conjugation to flavonoids and tannins [32, 33].  
Biosynthesis of gallic acid occurs through dehydrogenation of shikimic acid, 
unique to other polyphenols, which are generally synthesized through deamination of the 
aromatic amino acids.  Further synthesis of gallic acid to create more complex galloyl 
derivatives begins with esterification of glucose to gallic acid to form 1-O-galloyl-Β-D-
glucose or monogalloyl glucose; this is performed by a glucosyl transferase with UDP-
glucose as the substrate. Monogalloyl glucose is unique in that it acts as both a reactant 
and substrate in sequential synthesis to di, tri, tetra, and pentagalloyl glucose [34] 
(Figure 1). Hofmann and Gross discovered that galloyl substitution past pentagalloyl 
glucose require site specific enzymes named galloyltransferases which can add galloyl 
moieties to specific a galloyl group on pentagalloyl glucose [35]. The site specific 
galloyl transferases may be a reason for gallotannins poor separation in high 
performance liquid chromatography since hexa to nonagalloylglucose can have galloyl 
units synthesized in five potential positions.  
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Figure 1. Sequential synthesis of gallic acid to pentagalloylglucose [34]. 
 
 
 
The pathways that generate polyphenols are upregulated by stresses occurring 
from plant damage, UV exposure, and temperature, thus affecting the quantity of 
polyphenolics are found in the plant [36]. Over 8000 different polyphenols have been 
identified, and as such contain a wide variety of structures and classifications [32, 33]. 
The major classes of polyphenols include the hydroxybenzoic acids, cinnamic acids, 
flavonoids, tannins, stilbenes, and benzoquinones (Figure 2).  
 8 
 
 
Figure 2.  Parent structures of polyphenols subclasses [37]. 
 
 
 
2.2.2 Phenolic Acids 
Phenolic acids include both the hydroxybenzoic and hydroxycinnamic acids. 
Both have a benzene ring base with a carboxylic acid and differ structurally by the 
number of carbons between benzene and the acid group (Figure 2). The most prevalent 
hydroxybenzoic acid is 3, 4, 5-trihydroxybenzoic acid more commonly referred to as 
gallic acid. Gallic acid can be found in its free form or covalently linked to glucose or 
flavonoids [11, 29, 38]. Other than mango, gallic acid and galloyl glycosides are 
naturally present in a variety of foods, beverages, and herbs/spices including gallated 
flavan-3-ols in green tea, gallotannins in chickpea, cow peas, persimmons, star fruit, 
pecans, and sumac, and gallated ellagitannins in berries [39-41].  
The cinnamic acids are found more abundantly in the diet of Americans than the 
hydroxybenzoic acids in staples such as coffee and wheat. Chlorogenic acid, for example 
an ester of caffeic acid and quinic acid, is found extensively in coffee and one serving 
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can contain 70-350 mg [42]. Ferulic acid is another highly abundant cinnamic acid 
ranging from concentrations of 0.8-2.0 g/kg in wheat grains [43]. 
 
2.2.3 Flavonoids 
Flavonoids are the most studied and largest classes of polyphenols with over 
50% of the identified polyphenols belonging to this group. Flavonoids are widely 
distributed and are commonly found in the flowers and leaves of plants. Flavonoids can 
be further categorized into flavonols, flavanols, flavones, and anthocyanins with each of 
these groups having a similar backbone structure that includes three conjugated benzene 
rings with a C6-C3-C6 configuration with the differences between groups due to the 
presence of hydroxyl group and degree of saturation on C3 ring (Figure 2). Due to the 
large variety of flavonoids in fruits and vegetables, flavonoids are the most common 
polyphenol consumed in the human diet, and as such several reports are available on 
their potential health benefits [44]. 
 
2.2.4 Tannins 
Tannins are a class of polyphenols that have high molecular weights (300-3000 
Da) and the ability to precipitate proteins through hydrogen bonding due to the presence 
of  several galloyl or trihydroxyl functional groups [45]. Tannins have been used 
historically for their ability to ‘tan’ animal hides into leather, and are divided into two 
subclasses the condensed and hydrolysable tannins. Condensed tannins are polymers of 
the flavanols, catechin and epicatechin, and are commonly found in green tea, grapes, 
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wines, and chocolate. Hydrolysable tannins are synthesized through esterification of 
gallic acid to glucose, but differ from condensed tannins in that they can be hydrolyzed 
by either alkaline or enzymatic mechanisms. Gallotannins and ellagitannins make up the 
hydrolysable tannin subclass with ellagitannins being formed from degradation and C-
linkage of galloyl groups on gallotannins. Tannins are considered to be a double edge 
sword nutritionally as they have been found to have potent antimicrobial and antioxidant 
properties, yet they can also affect nutrient uptake and may potentially play a role in the 
formation of some cancers [46].   
 
2.3 Mango History and Composition 
2.3.1 The Mango Market 
Mangos (Mangifera inidica L.) are grown all over the globe with varieties 
available for consumption all throughout the year [47]. Cultivated in tropical and 
subtropical regions the majority of cultivation takes place in India, China, Mexico, 
Thailand, and Brazil with India accounting for greater than 50% of worldwide mango 
production [3]. In the United States mango consumption has steadily increased over the 
last fourteen years with a remarkable 56% increase in the amount of fresh mango fruit 
imported from 1998 to 2012 [48]. In the last decade, mango production has increased in 
areas that were not typical for mango cultivation such as South and Central America, 
Egypt, and Southeast Asia. Mango is enjoyed for its flavor and exotic taste, and the fruit 
is consumed in all stages of its development.  Unripe fruit is available in the form of 
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pickles and chutneys, and the fully ripened fruit is consumed raw and processed into 
purees, jams, and juices [3].  
In 2014 the United States imported over 370,000 metric tons of fresh mango 
alone from Mexico, Central, and South America and domestically produced <100,000 
metric tons [48]. As the majority of mango crop comes from the neighboring countries 
the cultivars that U.S. consumers are most likely to see in stores are Ataulfo, Haden, 
Keitt, Kent, and Tommy Atkins. Each of these varieties vary in flavor, size, and pulp 
consistency similar to the differences in apple varieties. 
 
2.3.2 Mango Composition and Physiology 
Fully ripened mango consists primarily of water and simple sugar; it contains 
approximately 1% combined fat and protein. The pulp of a ripe mango is yellow-orange 
in color due to the presence of carotenoids. Carotenoids are lipophilic hydrocarbons 
synthesized in organisms that utilize photosynthesis [49]. In these organisms, 
carotenoids function as aids to light harvesting, and protect the photo system from 
excess light and free radicals [50]. Only a few studies have been performed to 
characterize mango carotenoids in more than just a few varieties. Mercadante et al. 
found that the main carotenoids in two Brazilian mango varieties cv. Keitt and Tommy 
Atkins were all-trans -carotene, all-trans violaxanthin, and 9-cis violaxanthin. The 
same three carotenoids were found to be predominate in seven Mexican varieties (cv. 
Ataulfo, Haden, Tommy Atkins, Manila, Criollo, Kent, and Paraiso) as well [51].The 
quantity of carotenoids in the mango mesocarp has been reported to increase with fruit 
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ripening with a report by Mercandante et al. finding carotenoid levels in cv. Keitt 
increasing by over 200% in the transition from an un-ripened to fully ripened fruit [52, 
53].  
 
2.3.3 Mango Polyphenolics 
The composition of mango polyphenols in the pulp, peel, and seed is well 
documented across several varieties, and like all fruits and vegetables the content and 
concentrations of mango polyphenols differ based on soil, growing conditions, variety, 
and part of the plant [10, 12, 13]. Consistently reported in mango though are the galloyl 
derivatives in the form of free gallic acid, gallic acid glycosides, and gallotannins [11]. 
Saleh et al. were the first to characterize phenolic compounds in mango pulp with their 
study across 20 varieties using thin layer chromatography [54]. Though the content of 
phenolic compounds in the pulp depends largely on variety, presence of gallic acid 
derivatives is a constant.  Some cultivars (cv. Ataulfo) have high concentrations of 
gallotannins in the pulp while others do not. A recent focus has been to compare 
polyphenol content across varieties, an arduous task due to a large number of different 
varieties grown in various parts of the world [12, 13]. Knowledge of the differences in 
polyphenol content between varieties may be crucial to understanding mangos potential 
health benefits as different galloyl derivatives may have different bioefficacies. A 
similar but higher concentrated polyphenol profile is found in mango’s peel. While not 
commonly consumed in the United States the peel is consumed in several parts of the 
globe where mango is grown. Gallotannins, flavonoids, and the unique polyphenol to 
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mango, mangiferin, have been reported in relatively high quantities in the peel [9, 10, 
13]. 
 
2.4 Polyphenol Absorption, Metabolism, Distribution, and Excretion 
Due to the proposed health benefits of polyphenolics the past decade has seen 
hundreds of investigations regarding their metabolic fate, where they have been found to 
be very poorly absorbed [55-68].  Once consumed polyphenols will be digested and 
undergo absorption, distribution, metabolism, and excretion (ADME) similar to how 
drugs would be metabolized. The human body recognizes polyphenols as xenobiotics, 
foreign compounds that the body will try to eliminate through metabolism and excretion. 
Xenobiotic metabolism is one of the bodies numerous defensive systems and specifically 
is utilized in detoxifying potential harmful compounds. Xenobiotic metabolism can 
occur in all cells however higher concentrations of phase I and II enzymes are found in 
the liver or small intestine. A summary of the pathways of polyphenol metabolism can 
be found in (Figure 3).   
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Figure 3. Polyphenol absorption, metabolism, distribution, and excretion 
 
 
 
Before metabolism and distribution can take place, polyphenols must first be 
released from the food matrix and absorbed into the body.  Absorption of polyphenols is 
complex due to the differences in bioaccessibility (the amount of a dose that is available 
for absorption), solubility, presence of glycosides and acylation’s, and interactions with 
the food matrix [69]. Tannins are the conventional polyphenol that have been reported to 
have their bioaccessibility limited due to their ability to bind to proteins [70]. It is 
possible that polyphenols such as gallic acid and monogalloyl glucose that share the 
same galloyl or trihydroxyl functional group may have this same limited 
bioaccessibility. These interactions may limit the ability of some polyphenols to be 
absorbed in the small intestine, but could be beneficial in allowing them to reach the 
colon. Krook and Hagerman observed this in-vitro with epigallocatechin gallate and 
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pentagalloyl glucose, where each had higher stability at physiological conditions when 
paired with different food matrices [71]. 
Hydrophilicity and molecular weight are the most important factors when 
considering the absorption of a polyphenol into the enterocytes. Polyphenols are often 
glycosylated and are reportedly less absorbed than their aglycone counter parts [72]. 
Glycosylation of flavonoids increases their hydrophilicity and molecular weight and 
limits their absorption though passive diffusion. However the enzyme lactase phloridzin 
hydrolase found on the surface of epithelial cells is able to hydrolyze glycosides off 
some polyphenols allowing the now relativity hydrophobic polyphenols such as 
flavonoids to be absorbed through passive diffusion across the bi-lipid membrane [73].  
Smaller polyphenols such as the phenolics acids are too hydrophilic for passive 
diffusion across the plasma membrane and must be absorbed through different 
mechanisms. One study using the Caco-2 absorption model reported that p-coumaric 
acid was 100 times more absorbed than gallic acid [74]. Follow up investigations 
hypothesized that this was due to some phenolic acids such as p-coumaric acid being 
able to be transported through the monocarboxylic acid transporter, an active transport 
found in cells that transports lactate, pyruvate, and ketone bodies across plasma 
membranes [75]. Polyphenols with trihydroxyl groups such as gallic acid and 
epigallocatechin gallate may have their bioavailability limited through due to their high 
protein binding affinity. This may diminish their bioactivity, however a study by 
Johnston et al. revealed that these polyphenols may limit the absorption of 
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macronutrients such as glucose through inhibition of α-amylase activity implying 
absorption and metabolism may not be needed for their bioefficacy [76]. 
Fruits and vegetables are whole foods and when consumed many phytochemicals 
other than polyphenols are consumed alongside which may inhibit or enhance absorption 
rates. Peters et al. found that formulations of tea with sucrose and ascorbic could 
increase the bioavailability of tea catechins [77]. They hypothesized that this was due to 
inhibition of efflux transporters which have been reported to reduce polyphenol 
bioavailability. This same phenomenon is likely to occur with other polyphenols in foods 
that share these ingredients and may indicate that polyphenols are best consumed as 
whole foods. 
Once polyphenols are absorbed into a cell they will undergo xenobiotic 
metabolism similar to that of pharmaceuticals. The main function of xenobiotic 
metabolism is to assist in elimination of a foreign compound from the body and is 
divided into two phases, I and II. Phase I begins with oxidation reactions from the family 
of Cytochrome P450 oxidase enzymes. As non-polar compounds are more likely to be 
absorbed and distributed throughout the body Phase I reactions conjugate xenobiotics 
with polar functional groups (R=O, R-OH) which limits their ability to diffuse across 
cellular membranes [78]. Polyphenols by their nature already contain several hydroxyl 
groups, and have not been reported to participate in Phase I reactions. Metabolism 
proceeds with Phase II reactions where conjugations of methyl, glucuronide, and sulfur 
functional groups to the hydroxyl groups on polyphenols can occur with catechol-O-
methyl transferase (COMT), uridine diphosphoglucuronosyl transferases (UGT), and 
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sulfotransferases (SULT), respectively [79]. Once metabolized, polyphenols will either 
efflux by multidrug resistance proteins back to the small intestine or through the 
basolateral side to circulation where it will procede to the hepatocyte for additional 
metabolism [80]. Finally, if polyphenols are not sent back to the small intestine through 
liver bile they will enter systemic circulation before ultimately being excreted through 
the kidney.  
 Due to its high potential to be consumed in the human diet the ADME of gallic 
acid has been extensively studied. Figure 4 illustrates the proposed metabolism of 
galloyl derivatives. In 1959 Booth et al. analyzed rat urine after ingestion of tannic acid, 
and with the use of paper chromatography were able to identify gallic acid in the urine 
along with a methylated gallic acid [81]. Yasuda et al. performed the first study to truly 
begin to characterize the metabolites of gallic acid in rats with modern analytical 
techniques and were able to characterize two phase II metabolites in urine, 4-O-
methylgallic acid and 4-O-methylgallic acid-3-O-sulfate, after acute consumption of 
GA; these metabolites were characterized by a combination of their mass spectrum and 
NMR after acute consumption [82]. These studies report absorption and excretion 
happening quickly, with gallic acid and its metabolites being eliminated from the body 
within 2 h after consumption [65]. The ADME of monogalloyl glucoses has yet to be 
investigated, however, due to its higher molecular weight and size it is expected to have 
a lower bioavailability compared to gallic acid. Some reports are available on the 
bioavailability of pentagalloylglucose where low bioavailability is to be reported likely 
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due to a combination of its relatively large molecular weight, hydrophilicity, and protein 
binding capacity [58, 83]. 
 
2.4.1 Polyphenol Colonic Metabolism 
Trillions of bacteria are estimated to be in the human body with the majority 
residing in the GI tract, and is commonly referred to as the gut microbiota. The gut 
microbiota has been hypothesized to play a large role in the health of humans. The 
majority of polyphenols are not absorbed in the small intestine, meaning most will reach 
the colon where enzymes synthesized by microorganisms can catabolize polyphenols to 
produce a number of different hydrolytic products that will be sequentially available for 
absorption and metabolism.  
 
 
 
Figure 4.  The current proposed mechanisms on the ADME of gallic acid and galloyl 
glycosides  
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The growing importance of the gut microflora in metabolomics has led recent 
investigations to analyze their role in gallic acid metabolism. In two recent studies 
performed by Pimpão et al., 500 mL of a berry puree containing 425 mg gallic acid was 
fed to humans. Methyl and sulfated forms of pyrogallol, a decarboxylated gallic acid 
hypothesized to be sourced from the gut microbiota, were observed in human plasma 
and urine at higher concentrations compared to their source gallic acid [38, 55]. This was 
also observed after consumption of black tea extract where high concentrations of 
pyrogallol were detected up to 30 h after consumption [84]. The anti-cancer and anti-
inflammatory effects of pyrogallol metabolites should be investigated to determine if 
they have similar properties as gallic acid. 
Gallotannins are another substrate for enzymatic hydrolysis by the gut microflora 
due to bacteria that are capable of producing tannase, an enzyme capable of cleaving m-
depside and ester bonds. Tannase is produced by a number of bacteria where it is 
hypothesized to aid in microbial defense against tannins. Streptococcus galloyticus is 
one bacteria of note that can use tannins as a carbon source and one strain has been 
reported to live in concentration of up to 7% gallotannin [85]. Tannase has found 
industrial use for the production of gallic acid from tannic acid and aiding in the 
reduction of tea creaming. Release of gallic acid from enzymatic hydrolysis of 
gallotannins in vivo may give gallotannins additional bioefficacy as being a pool of pro 
gallic acid that can be released in the colon for absorption and metabolism. 
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2.4.2 Chronic Polyphenol Consumption 
Several studies have investigated the influence of extended polyphenol intake on 
inflammatory and other health biomarkers [86-91], yet only a few have looked at how 
chronic polyphenol consumption affects concentrations of polyphenols in blood and 
tissues. To accurately understand the mechanisms behind the health benefits of 
polyphenol consumption it is necessary that their metabolites be characterized and 
quantified in plasma and other sites of action. Conflicting results are reported, but 
indicate that habitual consumption will lead to higher levels of polyphenol metabolites in 
vivo. Ferruzi et al. have reported rats that consumed grape seed extract for 10 days were 
found to have a significantly higher concentration of gallic acid and catechin in plasma 
with repeated consumption [92]. However this trend was not observed for tea catechins 
in the plasma of humans who consumed green tea for 4 weeks [93]. The reports of 
habitual polyphenol consumption and its effects on colonic metabolism are even fewer 
given its only recent interest. However significant increases in excretion have been 
reported for colonic metabolites from both mango and cranberries [94, 95]. 
 
2.4.3 Polyphenol Metabolite Analysis 
Investigations characterizing and quantifying polyphenol metabolites in 
biological matrices cite the use of LC-MS as the instrument of choice. However, analysis 
of polyphenol metabolites contrast to that of their parent compounds present in fruits and 
vegetables due to conjugation of methyl, sulfate, and glucuronide functional groups as 
well as sample concentrations that are often at the nM level [96].  
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Table 1.  Plasma recoveries for gallic acid by use of solid phase and solvent extraction. 
 Method Concentration % Recovery 
Gasperotti et al. [97] 
Solid Phase 
Extraction 20 µg/L 53 
de Farrars et al. [98] 
Solid Phase 
Extraction 17 mg/L  <50% 
Ma et al. [99] Solvent 30 - 3000 µg/L 78-82 
Margalef et al. [61] 
Solid Phase 
Extraction 50 -500 mg/L 36-97 
Sun et al. [100] Solvent 40 – 8000 µg/L 80-88 
 
 
 
Sample preparation methods vary depending on the class of polyphenol being 
analyzed with most methods having a concentration step in hopes of increasing 
analytical sensitivity. The two most common methods for metabolite extraction in the 
literature are extraction of plasma with an organic solvent (acetonitrile, methanol, and or 
ethyl acetate) and micro solid phase extraction (SPE) with reverse phase 
chromatography [59, 61, 66, 101]. The recovery of gallic acid from these methods is 
mixed with recoveries ranging from 36 - 99% (Table 1). Greater recoveries are reported 
for the extraction of gallic acid from plasma by use of solvents for high concentrations of 
analyte in the sample, yet as those concentration are unlikely to be found in vivo they 
aren’t truly applicable for method development. Gallic acid has also been reported as 
one of the least recoverable polyphenolics most likely due to its protein binding affinities 
and high hydrophilicity compared to other phenolics making them difficult to partition 
with solvents or SPE. 
No reports are available on the recovery of gallic acid’s phase II metabolites 
from plasma likely due to the lack of analytical standards. It is possible that the 
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metabolites may have even lower recovery than the parent compound because of the 
additional methyl and sulfur groups, which may increase their ability to bind to proteins 
in plasma. Methylated epigallocatechin-gallate was found to have a higher plasma 
protein binding affinity than its non-conjugated form, and this same principle may carry 
over to gallic acid [102].  A method with increased efficiency for recovery of gallic acid 
and its metabolites is needed for accurate analysis in biological matrices. 
 In summary, while many absorption studies are available for gallic acid, little 
work has been performed on the ADME of monogalloyl glucose and gallotannins other 
than pentagalloylglucose to see what differences if any exist. A few studies have looked 
into the bioavailability of pentagalloylglucose, but with the growing importance of 
colonic microflora on polyphenolic metabolism there is a gap in knowledge with regards 
to how different galloyl derivatives are metabolized. As aforementioned, mango is 
unique in that it contains galloyl derivatives ranging from gallic acid all the way to the 
highly polymeric gallotannins making it the perfect vessel to study the ADME of 
different galloyl derivatives in a food matrix. 
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CHAPTER III  
QUANTIFICATION OF GALLIC ACID AND GALLOYL GLYCOSIDES IN FIVE 
MANGO CULTIVARS AND THE CHARACTERIZATION OF TANNASE 
HYDROLYSIS PRODUCTS  
 
3.1 Introduction 
Elevated consumption of fruits and vegetables is correlated with a reduction in 
the rates of cancer and cardiovascular diseases [17, 21], and has largely been attributed 
to the polyphenols, a class of phytochemicals found in higher plants that have a 
polyaromatic core attached with multiple hydroxyl groups. As a result, understanding the 
mechanisms behind polyphenols preventative effects is currently of great scientific 
inquiry.  Due to the diversity in chemical structures among polyphenolics it is important 
to individually investigate each compound to understand underlying mechanisms behind 
their potential health benefits. Mangos are a unique fruit as the polyphenolic content in 
their mesocarp is composed primarily of gallic acid, galloyl glycosides, and the 
polymerized gallotannins [11, 13, 103, 104]. Mango has had a 120% increase in the 
value of its imports to the U.S. over the past decade, and is perhaps one of the most 
popular fruits in the world, second only to bananas in global tropical fruit production 
[48]. Previous investigations have found significant differences in the composition of 
polyphenolics between various mango cultivars [12]. As the popularity of mango 
continues to increase and different varieties are brought to market, there is a need to 
characterize the phytochemical differences among cultivars that may relate to potential 
 24 
 
health benefits.  For example, gallic acid and pentagalloyl glucose are reported to have 
significantly different absorption rates despite similar functional groups [105]. For other 
polyphenolics, even the addition of functional groups such as hydroxyl or methoxy 
groups or the presence of a glycoside can affect absorption rates, as found by Hollman et 
al. (1995) who observed quercetin glycosides had higher absorption rates than quercetin 
aglycone [72, 106]. 
Tannins are a class of polyphenols found in a wide array of fruits, vegetables, 
and legumes that have been used for centuries as preservation agents in the process of 
turning animal hides into leather, and are additionally known for their ability to form 
complexes with protein and cause astringency in foods [39]. Tannins are categorized into 
two subtypes, condensed and hydrolysable. Condensed tannins are oligomers of flavan-
3-ols that are linked carbon to carbon via an interflavan bond. The hydrolysable tannins 
are further divided into gallotannins and ellagitannins. Gallotannins are polymers of 
gallic acid esterified to a polyol core, and ellagitannins are made from both gallic acid 
and hexahydroxydephenic acid moieties esterified to a polyol. In contrast to condensed 
tannins, hydrolysable tannins are polymerized through esterification of the monomeric 
units, and these ester bonds are capable of being hydrolyzed through both enzymatic and 
non-enzymatic means [71, 107]. Historically, tannins have been difficult to analyze due 
to poor separation even with high performance liquid chromatography, however some 
successful attempts have recently been made [108]. 
Tannase (tannin acyl hydrolase, EC 3.1.1.20) is an enzyme capable of 
hydrolyzing ester and depside bonds of hydrolysable tannins [109]. Tannase is produced 
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by several genera of fungi including but not limited to: Aspergillus, Penicillium, 
Fusarium, Trichoderma and bacteria, Lactobacillus spp and Streptococcus gallolyticus, 
and commercially is used to prevent creaming in instant tea, clarification of beer and 
fruit juice, and the production of acorn wine and coffee flavored beverages [110, 111]. 
Recent interest has been given to the tannase produced in the colon of individuals and its 
potential impacts on the digestion of foods, mainly through the release of gallic acid, 
which has been shown to possess anti-cancer and anti-inflammatory properties [16, 112]. 
However, inter-individual differences in tannase activity will affect the rate at which 
gallic acid is hydrolyzed and the efficiency of hydrolysis in vivo is unknown. The 
production of gallic acid by hydrolysis from tannase has been monitored in numerous 
studies alongside the characterization of the hydrolysis of tannic acid. However, the 
characterization of solely pentagalloyl glucose and monogalloyl glucose has not yet been 
investigated. Additionally, tannase has been reported to have different enzymatic 
activities for different galloyl substrates [113]. Investigating the effect of tannase on 
galloyl derivatives is of special interest for mango since tannase is found 
environmentally, in the leaves of mango trees, and is present innately in the gut 
microbiota of some individuals [114, 115]. Therefore, it was hypothesized that the rate 
and byproducts of hydrolysis with tannase may affect each distinct galloyl glucose 
differently. 
 In this work, five mango cultivars were investigated for their gallic acid, galloyl 
glycoside, and gallotannin content. Additionally, enzymatic hydrolysis with tannase was 
performed on monogalloyl glucose, pentagalloyl glucose, and a gallotannin isolate 
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extracted from mango in an effort to characterize and quantify hydrolysates over time. 
Results from these studies are aimed to quantify and characterize possible galloyl 
derivatives in mango pulp before and after enzymatic changes. 
 
3.2 Materials and Methods 
3.2.1 Fruit 
Mangos (cv. Ataulfo, Tommy Atkins, Keitt, Haden, and Kent) were sourced 
from Mexico through Frontera produce, and were allowed to ripen at room temperature. 
Fruit were manually peeled, deseeded, and vacuum sealed under good manufacturing 
practices. Mango pulp was held at -20oC until used for experiments.  
 
3.2.2 Chemicals 
Standards for gallic acid and pentagalloyl glucose were acquired from Sigma 
Aldrich (St. Louis, MO), and monogalloyl glucose acquired from CarboSynth 
(Berkshire, UK). Citric Acid and sodium carbonate were acquired from Fisher Scientific 
(Hampton, NH). Tannase (E.C. 3.1.1.20) sourced from Aspergillus oryzae was obtained 
from Kikkoman (Chiba Prefecture, Japan). HPLC grade 0.1% formic acid water and 
0.1% formic acid methanol were acquired from Sigma Aldrich. 
 
3.2.3 Mango Extracts and Tannin Fraction 
Polyphenol extracts for mango quantifications were prepared from 10 mg of 
homogenized mango pulp extracted with 30 mL of a 1:1 ratio of acetone and methanol in 
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triplicate. Solvents were evaporated under vacuum at 45 °C, and re-dissolved in a known 
volume of water acidified with 0.1 M HCl. An isolate consisting of only gallotannins 
was prepared from Ataulfo mango pulp and isolated as previously described by 
Hagerman (2011) [116]. Briefly, 500 mL of reagent alcohol was added to 500 mL of the 
polyphenol mango extract, and loaded on to a column filled with 20 g of Sephadex LH-
20 that was previously conditioned with 20 column volumes of reagent alcohol. Once 
the sample was loaded tannins were eluted using 80% acetone in water acidified with 
0.1% formic acid. The eluted gallotannin isolate was evaporated under vacuum, and 
stored at -20 °C until use. Conformation that only gallotannins remained in the isolate 
was performed by HPLC. 
 
3.2.4 Enzymatic Hydrolysis 
Standard solutions of monogalloyl glucose, pentagalloyl glucose, and a 
gallotannin isolate were incubated with tannase at 10-3 U/mL to characterize the 
byproducts and relative rates of galloyl derivative hydrolysis, and 250 μL of 200 ppm 
monogalloyl glucose or pentagalloyl glucose were incubated with 650 μL of buffer set to 
the enzyme's optimum conditions (pH 5.5, 0.1 M citric acid buffer, 30oC), and 100 μL of  
Tannase 10-3 U/mL for final standard concentrations of 50 ppm. For the gallotannin 
isolate, 250 μL of a 969 ± 31 ppm gallic acid equivalents determined by the Folin-
Ciocalteu method was used [117]. Experiments were performed in a static water bath 
and prepared in triplicate for each time point at 0, 1, 2, 3, 5, 10 min and 0.5, 1, 1.5, 2, 3, 
4 h. To end enzymatic activity solutions were immediately diluted with 1000 μL 0.1% 
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formic acid methanol. Lastly, samples were filtered with a Whatman 0.45 μm syringe 
filter prior to LC-MS analysis. 
 
3.2.5 LC-MS 
Galloyl derivatives were characterized and quantified by use of LC-MS on a 
Thermo Finnigan HPLC. Separations were in reversed-phase using a Finnigan Surveyor 
HPLC coupled to a Surveyor PDA detector and gradient separations were performed 
using a Phenomenex Kintex™ (Bannockburn, Il) C18 column, (150 x 4.6 mm, 2.6 µm) at 
room temperature. Injections were made into the column by use of a 50 μL sample loop. 
For separation of gallic acid and galloyl glycosides, mobile phase A was 0.1% formic 
acid in water and mobile phase B was 0.1% formic acid in methanol run at 0.45 mL/min. 
A gradient was run of 0% Phase B for 2 min and changed to 10% Phase B in 4 min, 10% 
Phase B was held to 10 min, 10 to 40% Phase B in 25 min, and 40% to 65% Phase B in 
35 min, 65% to 85% Phase B in 41 min, 85% was held to 49 min before returning to 
initial conditions. The electrospray interface worked in negative ionization mode. Source 
and capillary temperatures were set at 325°C, source voltage was 4.0 kV, capillary 
voltage was set at -47 V, and collision energy for MS/MS analysis was set at 35 eV. The 
instrument operated with sheath gas and auxiliary gas (N2) flow rates set at 10 units/min 
and 5 units/min, respectively. The instrument was tuned specifically for pentagalloyl 
glucose. Gallic acid and both monogalloyl glucoses were quantified at 280 nm with their 
respective standards. Di- and trigalloyl glucoses were quantified at 280 nm and reported 
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as equivalents of monogalloyl glucose. Tetragalloyl glucose and higher were quantified 
and reported as pentagalloyl glucose equivalents.  
 
3.3 Results and Discussion 
3.3.1 Quantification of Gallic Acid and Galloyl Glycosides in Five Mango Cultivars 
The polyphenolic content of fruits can differ based on ripeness, variety, and 
harvest conditions, however, previous investigations have all reported the polyphenolic 
content of mango pulp to be composed primarily of gallic acid and galloyl glycosides [9, 
12, 104, 118]. Historically, investigations on mango pulp have focused primarily on 
quantification of the total polyphenolic content, and characterization of flavonoids and 
gallotannins leaving the majority of the phenolic acids unquantified [10, 13]. A recent 
investigation by Krenek, Barnes, and Talcott (2014) characterized two monogalloyl 
glucoses which accounted for over 50% of the cv. Keitt mango’s non-tannin 
polyphenolic content [11]. Quantification of these two monogalloyl glucoses in other 
popular mango cultivars are needed as they likely attribute to mangos overall 
bioefficacy. In this work, the concentrations of gallic acid, monogalloyl glucoses, galloyl 
glycosides, and gallotannins were evaluated in the pulp of five mango cultivars, Ataulfo, 
Tommy Atkins, Keitt, Haden, and Kent. These five mango varieties are commonly 
found in grocery stores across the United States, and can be sourced from Mexico, 
Brazil, Ecuador, and Florida [3]. Characterization of the mango galloyl derivatives was 
performed from previously reported spectra and m/z (Table 2) [9, 11].  
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Table 2. Mass to Charge Ratios (m/z) and λmax for gallic acid, galloyl glycosides, and 
gallotannins. 
 
Compound 
λmax 
(nm) 
[M-H]- 
(m/z) 
[M-2H]2- 
(m/2z) 
MS/MS 
(m/z) 
gallic acid 271 169 - 125 
mono-galloyl glucose 278 331 - 271, 169, 125 
di-galloyl glucose 272 483  - 331, 271, 169 
tri-galloyl glucose 273 635  -  483, 422 
tetra-galloyl glucose 275 787 -  635, 465 
penta-galloyl glucose 279 939 469 - 
hexa-galloyl glucose 279 1091 545 - 
hepta-galloyl glucose 279 1243 621 - 
octa-galloyl glucose 279 1395 697 - 
nona-galloyl glucose 279 1647 773 - 
deca-galloyl glucose 279 1899 849 - 
unadeca-galloyl glucose  279 2003 1001  -  
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Figure 5. Concentrations (mg/kg) of gallic acid (GA), ester-monogalloyl glucose (Ester-
MGG), and ether-monogalloyl glucose (Ether-MGG) across five mango cultivars. 
  
 
 
Gallic acid was characterized from a m/z of 169 and max of 271 nm, and 
concentrations in the mango pulp were found to be at 21.6 ± 4.53, 11.3 ± 0.98, 5.69 ± 
0.11, 35.8 ± 0.81, and 41.3 ± 0.68 mg/kg for Ataulfo, Tommy Atkins, Keitt, Haden, and 
Kent, respectively (Figure 5). For the varieties, Haden and Kent, gallic acid was the 
highest concentrated non-tannin galloyl derivative in the pulp similar to report by 
Scheiber et al. where gallic acid was found to be the highest concentrated individual 
polyphenol at 6.9 mg/kg in a commercial mango puree [104]. The other predominate 
non-tannin galloyl glycosides were the two monogalloyl glucoses, ester-monogalloyl 
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glucose and ether-monogalloyl glucose which have previously been characterized by 
Krenek, Barnes, and Talcott (2014) with m/z of 331.2 and max of 278 nm [11]. Ester-
monogalloyl glucose has a glucose esterified to the acid group and fragmented into ions 
at m/z 271, 169, and 125 while the ether-monogalloyl glucose has a glucose covalently 
linked to a hydroxyl group on the 4 position and MS/MS fragments at m/z 169, 125 
(Figure 6). The concentration of ester-monogalloyl glucose for the five mango varieties 
was 189 ± 2.09, 25.3 ± 2.16, 29.7 ± 1.59, 35.8 ± 2.25, and 41.3 ± 2.6 mg/kg, and ether 
monogalloyl glucose was 2.52 ± 0.35, 11.4 ± 1.89, 5.08 ± 0.37, 10.91 ± 0.28, and 4.63 ± 
0.30 for Ataulfo, Tommy Atkins, Keitt, Haden, and Kent, respectively.  
The remaining galloyl derivative content included the galloyl glycosides, 
trigalloyl glucose and tetragalloyl glucose, and the gallotannins ranging from 
pentagalloylglucose to decagalloyl glucose (Figure 7) for the five cultivars was 3,040 ± 
962, 1,370 ± 58, 309 ± 36, 401 ± 41, and 127 ± 30 mg/kg for Ataulfo, Tommy Atkins, 
Keitt, Haden, and Kent, respectively. 
 
 
Figure 6. Chemical structures for gallic acid (A), ester-monogalloyl glucose (B), and 
ether-monogalloyl glucose (C). 
 33 
 
 
Figure 7. Chemical structures for trigalloyl glucose (A), tetragalloyl glucose (B), pentagalloyl glucose (C), and decagalloyl 
glucose.
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Ester-monogalloyl glucose was significantly higher in concentration across all 
mango cultivars except Haden when compared to ether-monogalloyl glucose (Figure 5), 
and was hypothesized to be due to ester-monogalloyl glucose being the precursor 
required for synthesis of gallotannins [34]. The Ataulfo cultivar had both the highest 
concentration of ester-monogalloyl glucose and gallotannins in comparison to other 
cultivars. In contrast, the two cultivars with the lowest concentration of ester-
monogalloyl glucose had the lowest total amount of gallotannins. Significant differences 
(p<0.05) were additionally found in the composition of gallotannins as well. Over 60% 
of the gallotannins in Ataulfo were heptagalloyl glucose (7GG) or larger. Conversely, 
Kent had the lowest concentration of total galloyl derivatives with over 60% of its 
gallotannin composition as pentagalloyl glucose (5GG) or smaller (Figure 8).The 
Ataulfo mango has previously been reported to be a superior cultivar in relation to its 
high polyphenolic concentration when compared to other mangos [119], and in this work 
it was the cultivar found to be the highest in total galloyl derivatives.  
 
 35 
 
 
Figure 8. Composition of gallotannins ranging in degree of polymerization from 
trigalloyl glucose (3GG) to decagalloyl glucose (10GG) across five mango cultivars. 
 
 
 
3.3.2 Characterization of Tannase Hydrolysis Intermediates 
Tannase sourced from Aspergillus oryzae was incubated with standard solutions 
of monogalloyl glucose, pentagalloyl glucose, and a gallotannin isolate sourced from 
mango in an effort to characterize and quantify the intermediates formed during 
hydrolysis. Prior investigations using hydrolysis with tannase have focused primarily on 
the substrates, methyl gallate, propyl gallate, epigallocatechin-gallate, and tannic acid, 
and specifically only on the rate of gallic acid production [120, 121]. Characterization of 
the different galloyl derivatives that can be formed during tannase hydrolysis is critical 
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as they are likely to have different rates of absorption, which will ultimately affect their 
health promoting properties.  
Hydrolysis of pentagalloyl glucose and other galloyl glycosides with tannase 
generates additional substrates upon hydrolysis, similar to the hydrolysis of glucose from 
maltodextrins with amylases. In this study after 2 h incubation of pentagalloyl glucose 
with tannase at 10-3 U/mL, 97.2 ± 0.27 % of the initial pentagalloyl glucose 
concentration had been hydrolyzed to create tertra-, tri-, digalloyl glycosides, and gallic 
acid (Figure 9). After 2 h, two tetragalloyl glucoses, six trigalloyl glucoses, and five 
digalloyl glucoses were characterized from m/z previously reported by (Table 2) [9]. 
Specifically, tetragallyol glucose was characterized from a parent ion at m/z 787 and 
fragment ions at m/z 635, 465 corresponding to the losses of galloyl moieties. Trigalloyl 
glucose at m/z 635 and fragments at m/z 483, 422, and 313, and digalloyl glucose was 
characterized from a parent ion at m/z 483 and fragment ions at m/z 331, 271, and 169.  
Concentrations of tetra-, tri-, and digalloyl glucoses changed significantly over 
the course of 2 h. At 0.5 h, the sum of tetragalloyl glucoses reached a maximum 
concentration of 49.2 ± 2.22 % of the total galloyl glycosides content, but at 2 h 
decreased to 13.8 ± 0.68%. In addition, di- and trigalloyl glucoses were still being 
synthesized and made up 10.4 ± 0.65 and 73.7 ± 1.92% of the total galloyl glycosides 
content, respectively. The six trigalloyl glucoses and five digalloyl glucoses each had 
distinct retention times (Figure 10), and were hypothesized to each have unique 
stereochemistry. The presence of numerous di- and trigalloyl glycosides indicates 
tannase randomly hydrolyzes the ester linkages to glucose. The hydrolysis of 
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pentagalloyl glucose with tannase directly contrast with its synthesis in plants, which 
follows a specific enzymatic pathway. In vivo, pentagalloyl glucose synthesis begins 
with the formation of monogalloyl glucose where subsequent enzymatic condensation 
reactions add additional galloyl groups to create 1,6-digalloyl glucose, followed by, 
1,2,6 -trigalloyl glucose, then 1,2,3,6-tetragalloyl glucose, and lastly 1,2,3,4,6-
pentgalloyl glucose, as previously discussed in Chapter II [34]. 
 
 
Figure 9. Hydrolysis of pentagalloyl glucose (5GG) and subsequent formation of 
tetragalloyl glucose (4GG), trigalloyl glucose (3GG), digalloyl glucose (2GG) following 
2 h incubation with tannase at 10-3 U/mL. 
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Figure 10. Chromatogram of five digalloyl glucoses and six trigalloyl glucoses at 280 nm (A) and extracted ion 
chromatograms at m/z 483.2 (B), and 635.2 (C) generated from hydrolysis of pentagalloyl glucose following 2 h incubation 
with tannase at 10-3 U/mL. 
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Thus, di- and trigalloyl glucoses are naturally found in plants that contain gallotannins as 
they are necessary for the formation of higher molecular weight gallotannins, but are 
observed in only two possible configurations, 1,6-digalloylglucose and 1,2,6-trigalloyl 
glucose [122]. The formation of numerous di- and trigalloyl glucoses from tannase 
hydrolysis has the potential to impact the bioefficacy of gallotannins as bacteria residing 
in the gut microbiota of humans have been reported to express tannase [115]. As a result, 
these newly characterized di- and trigalloyl glucoses are hypothesized to each have a 
distinct bioavailability which should be investigated to fully elucidate the potential 
health benefits of gallotannin consumption. 
On a molar basis 45.5 ± 0.53% of the total potential gallic acid content was 
generated from hydrolysis of pentagalloyl glucose following 2 h of incubation. When an 
equivalent concentration of monogalloyl glucose (20 mg/L) was incubated with the same 
duration and tannase activity only 28.9 ± 0.26 % of the total potential gallic acid was 
generated, a significant (p<0.05) difference (Figure 11). It took a total of 4 h for 
monogalloyl glucose to reach the same amount of gallic acid generated by pentagalloyl 
glucose, despite there being more moles of monogalloyl glucose compared to 
pentagalloyl glucose. This observation could be due to differences in enzymatic 
activities at specific galloyl-glucose positions. Wu et al. (2015) previously demonstrated 
that tannase can have different activities for various galloyl substrates, and when tannase 
sourced from Lactobacillus plantarum was incubated with methyl gallate, digallic acid, 
and tannic acid it was found to have enzymatic activities of 272, 16.8, and 10.4 U/mg, 
respectively [113]. Therefore, results from these experiments suggest tannase has 
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different enzymatic activates for each position of a galloyl group on the glucose core of 
pentagalloyl glucose. 
 
 
Figure 11. Hydrolysis of monogalloyl glucose (MGG) and subsequent formation of 
gallic acid (GA) following 4 h incubation with tannase at 10-3 U/mL. 
 
 
 
A mango gallotannin isolate extracted from the Ataulfo cultivar containing 
tannins ranging in degree of polymerization from pentagalloyl glucose to undecagalloyl 
glucose was incubated with tannase at 10-3 U/mL (Figure 12). After 2 h, all gallotannins 
were still quantifiable indicating that there was not a preference for one gallotannin over 
others by the enzyme. Tetragalloyl glucoses and pentagalloyl glucoses all significantly 
increased in concentration to 3.22 ± 0.04 and 7.48 ± 0.13% of total galloyl derivatives, 
respectively. Trigalloyl glucoses and gallic acid were not detected initially and after 2 h 
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hydrolysis represented 1.31 ± 0.01 and 2.41 ± 0.02% of the total galloyl derivatives. No 
digalloyl glucoses or monogalloyl glucose were characterized or quantified within the 2 
h hydrolysis. In addition, no digallic acid or trigallic acid were characterized whose 
presence would indicate direct hydrolysis of galloyl-glucose bonds of the larger 
gallotannins instead of just the depside bonds connecting the gallic acids together. Ren et 
al. (2013) previously described the structure and binding site of a galloyl in tannase 
produced by Lactobacillus plantarum, and found that there was only one binding site for 
both depside and esterase activities, and that only a single galloyl moiety enters the 
binding site at a time [123], which would explain the lack of digallic acid and trigallic 
acid. 
 
 
Figure 12. Hydrolysis of gallotannin isolate ranging in composition from tetragalloyl 
glucose (4GG) to undecagalloyl glucose (11GG) following 2 h incubation with tannase 
at 10-3 U/mL. 
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3.4 Conclusions 
The pulp of Ataulfo, Tommy Atkins, Keitt, Haden, and Kent mango cultivars 
were investigated for their galloyl derivative content. Ataulfo had the highest among all 
cultivars with 21.6 ± 4.53 mg/kg of gallic acid, 189 ± 2.09 mg/kg of ester-monogalloyl 
glucose, and 3,040 ± 962 mg/kg of gallotannins while Kent had the lowest with 41.3 ± 
0.68 of gallic acid, 41.3 ± 2.6 mg/kg of ester-monogalloyl glucose, 127 ± 30 mg/kg and 
of gallotannins. Additionally, the enzymatic hydrolysis of gallotannins with tannase was 
evaluated and the intermediates characterized, and when pentagalloyl glucose was 
hydrolyzed two tetragalloyl glucoses, six trigalloyl glucoses, and five digalloyl glucoses 
were characterized each hypothesized to have unique stereochemistry and as a result a 
unique bioavailability. Galloyl glycosides and other gallated species are found in many 
foods stuffs and have the potential to affect the diet of a large percent of the global 
population.  
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CHAPTER IV 
IN VITRO BIOACCESSIBILITY AND IN VIVO ABSORPTION OF MANGO 
GALLIC ACID AND GALLOYL GLYCOSIDES 
 
4.1 Introduction 
Once considered an exotic delicacy, tropical fruits are gaining popularity in the 
United States for their sensorial properties, antioxidant capacity, and potential health 
benefits, and within the last decade, the mango imports to the United States have 
doubled in value to over $430 million [48]. Extracts from mango pulp, peel, and kernel 
have been shown to be an antagonist to chronic diseases such as diabetes, cancer, and 
inflammation and are rich in a wide array of phytochemicals including carotenoids, 
vitamin C, and polyphenols [124, 125]. The principal polyphenols in mango are the 
galloyl derivatives, that include gallic acid, gallic acid glycosides, and gallotannins that 
may range in polymerization from five to twelve galloyl moieties [12].  
While several health benefits have been attributed to polyphenols it is possible 
that these benefits are limited due to low bioavailability [79], and this includes 
incomplete dissolution from foods at various stages of digestion. The bioavailability of a 
polyphenol is a result of its capacity to be transported across an enterocyte while its 
bioaccessibility is defined as the amount of compound in solution and available for 
absorption. Differences in bioavailability among polyphenolics are a result of a complex 
balance between a compound’s size, polarity, presence of glycosides or acylation, and 
interaction with the food matrix [126]. The bioavailability, metabolism, and potential 
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health promoting properties of both gallic acid and pentagalloyl glucose have previously 
been studied [92, 112], however little is known regarding the metabolic fate of 
monogalloyl glucose that may account for more than 50% of non-tannin polyphenol 
content in some mango varieties [11]. In addition, the hydrolysis of galloyl derivatives 
through enzymatic and non-enzymatic reactions releases free gallic acid and shapes the 
metabolic reactions taking place upon digestion [127]. 
Mango is cultivated in tropical and sub-tropical climates and is arguably one of 
the world’s most popular fruits [3]. As such, mango has the potential to affect the diets 
in many global regions. Understanding the digestion and absorption of galloyl 
derivatives is critical in the interpretation of potential health benefits of not only mango 
but of other fruits, nuts or botanicals rich in gallated polyphenolics. The aim of this work 
was to determine the bioaccessibility of mango galloyl derivatives using in vitro 
digestion conditions. Additionally, the absorption of monogalloyl glucose and free gallic 
acid was determined using a Caco-2 monolayer transport model and a pilot in vivo 
porcine absorption model. 
 
4.2 Materials and Methods 
4.2.1 Mango Fruit 
Mature Mexican mangos (cv. Ataulfo) were kindly imported and donated by 
Frontera Produce (Edinburg, TX) and the National Mango Board and shipped 
refrigerated to the Department of Nutrition and Food Science at Texas A&M University. 
Fruit were allowed to ripen at ambient conditions, and fruit that exhibited uniform 
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ripeness based on skin color and manual texture determination were manually peeled, 
deseeded, cubed, and stored at -20°C in vacuum sealed bags under Good Manufacturing 
Practices.  
 
4.2.2 Chemicals  
Standards of gallic acid, ethyl gallate, pentagalloylglucose, porcine lipase, bile, 
and pancreatic enzymes were purchased from Sigma Aldrich (St. Louis, MO). A 
standard of monogalloyl glucose was purchased from Carbosynth Chemicals (Berkshire, 
UK). Methanol, ethanol, acetone, ethyl acetate, and gastric juice containing pepsin were 
purchased from Fisher Scientific (Hampton, NH). HPLC grade 0.1% formic acid water 
and 0.1% formic acid methanol were purchased from Sigma Aldrich (St. Louis, MO).  
 
4.2.3 Quantification of Galloyl Derivatives 
Galloyl derivatives from mango pulp were quantified by HPLC and served as a 
basis for comparison in bioaccessibility experiments. Homogenized mango pulp (10 g) 
was extracted with 50 mL of extraction solvent containing 1:1 methanol and acetone. 
The mixture was stirred for 30 min, filtered through Whatman #4 filter paper, and the 
remaining solids re-extracted twice under the same conditions. The solvents were 
evaporated under reduced pressure at 45°C and the concentrate dissolved in 30 mL of 
water with 0.01% formic acid. Samples were filtered through a Whatman 0.45μm PTFE 
membrane prior to characterization and quantification by HPLC-MS.  
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4.2.4 In Vitro Bioaccessibility 
In vitro digestion conditions for assessing polyphenol bioaccessibility were 
similar to previously described models with some modifications [128, 129]. In triplicate, 
10 g of homogenized mango pulp or 10 g of 0.65 mm3 mango cubes were placed in 50 
mL Falcon tubes. Deionized water (4 mL) was added along with 12 mL of commercial 
gastric digestion solution containing pepsin to reach a pH of 2.0 ± 0.1, simulating 
stomach conditions. Samples were held in a ThermoFisher SWB25 (Hampton, NH) 
shaking water bath at 37 °C. At 0, 1, and 2 h aliquots were removed, centrifuged for 2 
min at 4,000 x g, and 1 mL of supernatant obtained for analysis. Following gastric 
digestion, 0.2 M Na2CO3 (16 mL) along with 0.5 mL of a digestive enzyme mixture (2.4 
mg/mL bile, 0.4 mg/mL pancreatin, and 0.2 mg/mL lipase) were added to raise the pH to 
7.1 ± 0.1 and simulate the conditions of the small intestine and colon. Samples were 
flushed with nitrogen to create an anaerobic environment and returned to the water bath. 
At 2, 4, 6, and 8 h aliquots were again centrifuged and 1 mL of supernatant collected. 
Each aliquot was immediately acidified with 0.1 mL of 88% formic acid, centrifuged at 
10,000 x g for 5 min, and filtered through a 0.45μm membrane filter for HPLC-MS 
analysis. The bioaccessible fraction was calculated by the ratio of the amount (mg) of 
polyphenol in the supernatant to the initial amount (mg) in 10 g of mango pulp. As a 
control, a mango extract was likewise prepared from 1 kg of mango, using extraction 
procedures outlined in Section 2.3. This mango extract and a 10 mg/L standard solutions 
of gallic acid and monogalloyl glucose underwent the same in-vitro digestion procedures 
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as the homogenized cube and pulp and represented solutions containing 100% 
bioaccessible polyphenols. 
Following the 10 h in vitro digestion, the amount (mg) of insoluble galloyl 
derivatives remaining in the digested homogenized mango pulp and cubed mango were 
additionally extracted and quantified. Galloyl derivatives were isolated by centrifuging 
remaining digests for 5 min at 4,000 followed by vacuum filtration using Whatman #4 
Filter paper for 5 min. The insoluble material was extracted as previously described in 
Section 2.3, solvents evaporated, reconstituted into acidified water acidified, and filtered 
through a 0.45 μm membrane for HPLC-MS analysis.  
 
4.2.5 Caco-2 Monolayer Transport 
Gallic acid, monogalloyl glucose, and pyrogallol were evaluated in a Caco-2 
monolayer trans-epithelial transport model. Caco-2 transport model procedures were 
based of procedures as previously described [130]. Caco-2 cells were acquired from 
ATCC (Manassas, VA), and cultured in media containing 84% fetal bovine serum, 4% 
penicillin, 4% glutamine, 4% sodium pyruvate, and 4% amino acids. Cells between 10-
30 passages were seeded on to 2 mm transparent polyester cell culture insert well plates 
(Transwell, Corning Costar Corp., Cambridge, MA) at 1.0 × 105 cells per insert with 0.5 
mL of medium in the apical side and 1.5 mL of medium in the basal side. Monolayers 
grew for 21 days and confluence was measured by resistance with an EndOhm Volt 
ohmmeter equipped with a STX-2 electrode (World Precision Instruments Inc., Sarasota, 
FL); monolayers with a resistance of (> 450 Ω cm2) were used for experiments. Gallic 
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acid, monogalloyl glucose, and pyrogallol were applied to apical layer at 50 mg/L, and 
200 μL aliquots were taken from the basal layer at 0.5, 1, 1.5, and 2 h, and replaced with 
200 μL of media. Aliquots were acidified with 2.5 μL 88% formic acid prior to HPLC-
MS analysis.  
 
4.2.6 Porcine Model 
In the porcine absorption model, a female crossbred piglet (32 kg, aged 10 wks) 
was obtained from a commercial breeder in Rosenbaum Farms, Brenham, TX, USA. 
Care of the animal in preparation for surgical procedures and post-surgical care was 
performed as previously described [131]. One week prior to surgery the piglet was 
adapted to its environment inside a 2 x 3 m kennel at 21-25 °C and fed a diet lacking 
polyphenols (Research Diets Inc, New Brunswick, NJ). Surgery was then performed to 
insert dwelling catheters into the stomach and caval vein to enable rapid infusion of 
polyphenols and blood sampling. Post-surgery, the pig was familiarized to a movable 
cage (0.9 m x 0.5 m x 0.3 m) with experiments beginning 1 wk later. The study protocol 
was approved by the Institutional Animal Care and Use Committee of Texas A&M 
University prior performing the animal experiment.  
Gallic acid and monogalloyl glucose were administered orally in independent 
experiments via the stomach catheter at a dose of 32 mg /kg of body weight in a 100 mL 
0.2 M citric acid vehicle at a pH of 3.5. Blood collection times were 0.25, 0.5, 0.75, 1, 
1.5, 1.75, 2, 3, 4, 5, 6, 8, and 10 h post oral administration at 2 mL per collection through 
the venous port. Collected blood was centrifuged for 5 min at 3,500 x g, and 500 μL 
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plasma was aliquoted and acidified with 25 μL 88% formic acid. Prior to LC-MS 
analysis, 50 μL of ethyl gallate as the internal standard was infused with the plasma, and 
samples were precipitated with 150 μL of 10% SDS and 300 μL methanol. Samples 
were spun at 10,000 x g for 5 min and the supernatant filtered through a 0.45 μm filter.  
Additionally, gallic acid and monogalloyl glucose were administered intravenously in 
independent experiments via the dwelling catheter of the venous port at a dose of 48 mg.  
The doses were administered in a 50 mL vehicle containing sodium carbonate buffered 
to a pH of 7.0. Prior to administration vehicles were sterile filtered via a 0.22 μ filter. 
Following administration, the catheter was flushed with saline and a sample was 
immediately taken for a baseline concentration. Additional blood samples were collected 
at 2.5, 5, 7.5, 10, 15, 20, 30, 60, 90, and 120 min, and were processed in the same 
manner as the samples in the oral administration. Non-compartmental pharmacokinetic 
analysis was conducted for both oral and intravenous administrations with the PKSolver 
add-in for Microsoft Excel 2013 [132]. Absolute bioavailability was calculated using: 
𝑓 =
AUCOral *DoseIV
AUCIV*DoseOral
 with ƒ as absolute bioavailability and AUC as area under the 
curve. Results were calculated from two independent extractions of porcine plasma and 
reported as the mean ± standard error of the mean.  
 
4.2.7 Chemical Analysis 
Galloyl derivatives were quantified using a Thermo Finnigan LCQ Deca XP Max 
MSn ion trap mass spectrometer equipped with an ESI source. Separations were in 
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reversed-phase using a Finnigan Surveyor HPLC coupled to a Surveyor PDA detector 
and gradient separations were performed using a Phenomenex Kinetex™ (Bannockburn, 
Il) C18 column, (150 x 4.6 mm, 2.6 µm) at room temperature. Injections were made into 
the column by use of a 50 μL sample loop. For separation of gallic acid and monogalloyl 
glucose mobile phase A was 0.1% formic acid in water and mobile phase B was 0.1% 
formic acid in methanol run at 0.45 mL/min. A gradient was run of 0% Phase B for 2 
min and changed to 10% Phase B in 4 min, 10% Phase B was held to 10 min, 10 to 40% 
Phase B in 25 min, and 40% to 65% Phase B in 35 min, 65% to 85% Phase B in 41 min, 
85% was held to 49 min before returning to initial conditions. The electrospray 
ionization interface was in negative ionization mode, source and capillary temperatures 
were set at 325°C, source voltage was 4.0 kV, capillary voltage at -47 V, and collision 
energy for MS/MS analysis was 35 eV. The instrument operated with sheath gas and 
auxiliary gas (N2) flow rates set at 10 units/min and 5 units/min, respectively. The 
instrument was tuned for gallic acid and along with monogalloyl glucose was quantified 
at 280 nm and the gallic acid metabolites 4-O-methylgallic acid and 4-O-methylgallic 
acid-3-O-sulfate were quantified using extracted ion chromatograms.  
A second analysis protocol was used to separate and quantify gallotannins using 
a 250 x 4.6 mm, 2.6 µm Waters Sunfire C18 column (Milford, MA), and the conditions 
of Luo et al. (2014) with modification [103]. Mobile phase A was 0.1% formic acid in 
water and Mobile phase B was 0.1 % formic acid in acetonitrile run at 0.6 mL/min. A 
gradient of 10% Phase B was run for 2 min and changed to 25% Phase B at 6 min, 35% 
Phase B was held to 30 min, 35 to 45% Phase B in 35 min, and 45% to 55% Phase B in 
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40 min then returned to initial conditions. In negative ionization mode, source and 
capillary temperatures were set to 325°C, source voltage to 4.0 kV, and capillary voltage 
at -43 V. Sheath gas and auxiliary gas were likewise set to 10 units/min and 5 units/min, 
respectively. The instrument was tuned for pentagalloyl glucose and gallotannins 
quantified using extracted ion chromatograms. 
 
4.2.8 Statistics  
In vitro digestion and Caco-2 experiments were evaluated in triplicate and in 
independent reaction vessels. For the porcine model, two independent plasma extractions 
were performed prior to LC-MS analysis. Statistical differences were compared using 
unpaired student’s t-test in JMP software. All values are reported as the mean ± standard 
error the mean. 
 
4.3 Results and Discussion 
4.3.1 Galloyl Derivatives in Mango cv. Ataulfo 
Previous reports have documented the high concentrations of gallated phenolics 
and gallotannins in the pulp of the Ataulfo cultivar compared to other mango varieties 
[118, 119]. Eight galloyl derivatives where characterized in the Ataulfo pulp used in 
these studies which included gallic acid, esterified monogalloyl glucose, and six tannins 
ranging in degree of galloyl conjugation from 5 to 10 galloyl groups (Table 3). 
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Table 3. Characterization and concentrations (mg/kg) of galloyl derivatives in mango (cv. Ataulfo) pulp. 
Compound 
λmax 
(nm) 
[M-H]-  
(m/z) 
[M-2H]2- 
(m/2z) 
MS/MS 
(m/z) 
Concentration 
(mg/kg) 
mono-galloyl glucose 278 331.2 - 271.1, 169.2, 125.3 229 ± 9.331 
gallic acid 271 169.2 - 125.3 9.09 ± 0.170 
penta-galloyl glucose 279 939 469 - 6.56 ± 1.20 
hexa-galloyl glucose 279 1091 545 - 38.9 ± 7.04 
hepta-galloyl glucose 279 1243 621 - 86.9 ± 10.4 
octa-galloyl glucose 279 1395 697 - 90.5 ± 9.94 
nona-galloyl glucose 279 1647 773 - 118 ± 9.35 
deca-galloyl glucose 279 1899 849 - 68.4 ± 7.34 
1. Values are reported as the mean ± SEM 
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Characterizations were based on UV and mass spectra compared to published values for 
these compounds [9, 104]. Monogalloyl glucose was present in the highest concentration 
at 229 ± 9.3 mg/kg compared to 9.09 ± 0.17 mg/kg for free gallic acid. Cumulatively, the 
six gallotannins totaled 409 ± 45.4 mg/kg and individually ranged in concentration from 
6.56 ±1.20 mg/kg for pentagalloyl glucose and 117 ± 9.34 mg/kg for nonagalloyl 
glucose when quantified in equivalents of pentagalloyl glucose.  
 
4.3.2 In Vitro Bioaccessibility  
The bioaccessibility of mango polyphenolics from homogenized mango pulp and 
cubed mango was compared to a 100% bioaccessible mango extract that served as a 
control under in vitro digestion conditions (Figure 13). Monogalloyl glucose was readily 
soluble in the gastric solution at 0 h in both homogenized mango pulp and cubed mango 
with an initial bioaccessibility of 75.1 ± 6.25%, and 61.0 ± 5.80%, respectively, and no 
significant (p<0.05) changes occurred during the first 2 h under gastric conditions. At 4 
h, 2 h following the pH transition from the stomach to the intestines, the bioaccessibility 
of monogalloyl glucose significantly increased for homogenized and cubed mango to 
98.0 ± 4.58% and 85.0 ± 10.58%, respectively, while the concentration of monogalloyl 
glucose in the mango extract decreased to 81.2 ± 2.49% of its initial concentration. This 
indicates that the mesocarp structure may be critical in stabilizing monogalloyl glucose 
in both digestive acidic or alkaline conditions. Krook and Hagerman (2012) have 
previously demonstrated the ability of a food matrix to increase the stability of a  
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Figure 13. Bioaccessibility of monogalloyl glucose in (A) mango extract, (B) homogenized mango pulp, and (C) cubed mango 
and free gallic acid in (D) mango extract, (E) homogenized mango pulp, and (F) cubed mango under in vitro digestion 
conditions at 37 °C, pH 2.0 for 2 h and pH 7.1 for 8 h, with digestive enzymes.
 55 
 
polyphenol in intestinal conditions with standards of pentagalloyl glucose and 
epigallocatechin gallate when incubated with proteins, starches, and fiber [71]. After 10 
h of digestion, a significant loss in monogalloyl glucose was observed and 
concentrations decreased to 61.6 ± 7.98%, 57.9 ± 5.23%, and 52.1 ± 8.41% for the 
mango extract, homogenized mango pulp, and cubed mango, respectively. Likewise, 
when a standard of monogalloyl glucose was held under in vitro digestion conditions 
only 60.3 ± 2.41% remained after 10 h (Figure 14). Polyphenols are prone to auto-
oxidation under duodenal to colonic pH conditions, and this may lead to a progressive  
 
 
Figure 14. Stability of gallic acid and monogalloyl glucose following in vitro digestion 
at 37 oC pH 2.0 for 2 h and pH 7.1 for 8 h, with digestive enzymes. 
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formation of oxidized and polymerized compounds in the small and large intestines 
[133]. Results suggest that when polyphenol bioaccessibility is increased during 
digestion, as observed for homogenized and cubed mango pulp, its concentration may 
rapidly decrease due to instability under elevated pH conditions.  
As opposed to monogalloyl glucose, mango gallotannins were found to have 
limited bioaccessibility following in vitro digestion with no quantifiable amounts of 
gallotannins in the digestion solution. When post-digestion solvent extractions were 
performed on the fruit preparations, it was found that 51.5 ± 8.12% and 88.5 ± 1.03% of 
the initial amount of gallotannins remained in the fruit matrix for homogenized mango 
pulp and cubed mango, respectively (Figure 15). The amount of gallotannins remaining 
in the cubed mango matrix was significantly (p<0.05) higher compared to homogenized 
mango pulp and this mirrored a previous study with mango where the degree of fruit 
maceration was significantly correlated to increased carotenoid bioaccessibility [134]. 
Upon ingestion, gallotannins bound to the food-matrix in the fruit pericarp may become 
bioaccessible due to the microbial degradation of pectins and other cell wall materials by 
intestinal microflora [135]. The release of mango gallotannins in the colon could lead to 
potential health benefits; mainly through enzymatic hydrolysis to produce bioaccessible 
gallic acid and pyrogallol, the major microbial metabolite [136].   
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Figure 15. Gallic acid, monogalloyl glucose, and gallotannins bound to cellular matrices 
of homogenized mango pulp and cubed mango following in vitro digestion at 37 °C pH 
2.0 for 2 h and pH 7.1 for 8 h with digestive enzymes. 
 
 
 
Free gallic acid significantly (p<0.05) increased after 10 h of the in vitro 
digestion by 384 ± 14.9%, 490 ± 9.68% and 233 ± 15.8% for mango extract, 
homogenized mango pulp, and cubed mango, respectively (Figure 13). Gallic acid 
commonly experiences extensive degradation when exposed to physiological pH 
conditions and when an authentic standard was incubated under in vitro digestion 
conditions the amount of gallic acid decreased to 45.4 ± 2.51% of its initial 
concentration over 10 h (Figure 14). This indicates that the gallic acid concentration 
determined after 10 h is a result of simultaneously occurring generation from gallotannin 
hydrolysis and degradation of gallic acid under intestinal pH conditions [137]. In 
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contrast, monogalloyl glucose is not likely to be a source of hydrolyzed gallic acid as 
when monogalloyl glucose was incubated alone under in vitro digestive conditions free 
gallic acid was not produced. In vitro digestion of mango extract and homogenized pulp 
resulted in significantly higher amounts of bioaccessible gallic acid in conjunction with a 
greater concentration of gallotannins being released into solution while significantly less 
gallic acid was produced from cubed mango. This indicates that the majority of 
gallotannins in cubed mango may be able to reach the colon and be available for 
microbial metabolism, potentially resulting in higher production of pyrogallol. It is 
unknown how these differences might affect bioactivity, however pyrogallol the 
principle colon metabolite of gallic acid has been reported to have anti-carcinogenic 
properties [138, 139], and it may be beneficial to choose a food matrix that retains 
gallotannins throughout upper intestinal digestion to support its generation in the colon. 
 
4.3.3 Caco-2 Monolayer Transport  
For the first time the transport of monogalloyl glucose was evaluated in a Caco-2 
monolayer model and compared to gallic acid and pyrogallol. Physiologically, the 
absorption of polyphenolics from the small intestine is governed by stereochemistry and 
polarity, and many higher molecular weight polyphenols or those with polar functional 
groups are less likely to be absorbed [72]. Gallic acid and monogalloyl glucose were 
separately applied to the apical layer at 50 μg/mL and their transport rates (apical to 
basolateral) were 160 ± 59.4 µg/ml·h and 257 ± 43.1 µg/ml·h, respectively (Table 4). 
The hydrophilicity of gallic acid decreases its ability to partition across the bi-lipid  
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Table 4. Transport of 50 μg/mL gallic acid, monogalloyl glucose, and pyrogallol across the apical to basolateral side of Caco-2 
monolayers over 2 h. 
 % Transport  Transport Rate (μg/mL·h)
 
 0.5 h 1 h 1.5 h 2 h    
gallic acid 
0.23 ± 
0.051,a 
0.52 ± 
0.15a 
0.58 ± 
0.15a 
0.67 ± 
0.13a  
 
160 ± 59.4a 
monogalloyl glucose 
0.10 ± 
0.01a 
0.23 ± 
0.02a 
0.72 ± 
0.10a 
0.98 ± 
0.14a 
 
257 ± 43.1a 
pyrogallol 
1.55 ± 
0.34b 
3.51 ± 
0.11b 
5.55 ± 
0.90b 
4.19 ± 
0.53b 
 
1860 ± 3412,b 
1. Values are reported as the mean ± SEM, and different letters in the same column are significantly different (p < 0.05). 
2. Transport rate for pyrogallol was calculated only to 1.5 h. 
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membrane of an enterocyte and its proposed mechanism for absorption was 
hypothesized to be through para-cellular transport [74]. After 2 h of transport, 0.98 ± 
0.14% of monogalloyl glucose had transported compared to the 0.67 ± 0.13% for gallic 
acid, a non-significant difference. With similar transport rates it is possible that 
monogalloyl glucose transports through the same mechanism as gallic acid, however 
given the glucose moiety there is potential for glucose transporter interactions [76]. 
Pyrogallol had a significantly (p<0.05) higher transport rate, 1,860 ± 341 µg/ml·h, and 
the amount transported after 2 h, 4.19 ± 0.53%, when compared to either gallic acid or 
monogalloyl glucose. While not innately present in mango, pyrogallol has been reported 
to be the main colonic metabolite of gallic acid due to bacterial decarboxylase activity 
[140, 141]. From 1.5 to 2 h the amount of pyrogallol transported significantly (p<0.05) 
decreased from 5.55 ± 0.90% to 4.19 ± 0.53%. Pyrogallol is exceptionally unstable 
compared to other polyphenolics especially under low acid conditions, and this may 
have resulted in an under-estimation of actual basolateral concentrations [142]. 
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Table 5. Pharmacokinetic parameters for gallic acid and monogalloyl glucose following oral and IV administration in a 10 h 
pilot porcine absorption study. 
 Oral  IV   
 Cmax Tmax AUCoral  AUCIV Half-life Vd  Bioavailability abs
1 
 (mg/L) (h) (mg/L*h)  (mg/L*h) (h) (L)  (%) 
gallic acid 3.42 ± 
1.07 
0.5 
3.57 ± 
0.07 
 
0.98 ± 
0.20 
0.10 ± 
0.04 
4.54 ± 
1.1 
 19.3 ± 4.40 
monogalloyl 
glucose 
0.13 ± 
0.05 
0.5 
0.09 ± 
0.03 
 
2.71 ± 
1.31 
0.34 ± 
0.05 
10.9 ± 
2.18 
 0.28 ± 0.20 
1. Absolute bioavailability was calculated using: 𝑓 =
AUCOral *DoseIV
AUCIV*DoseOral
 , with ƒ as absolute bioavailability and AUC as area 
under the curve. 
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4.3.4 Bioavailability of Gallic Acid and Monogalloyl Glucose in a Porcine Model 
The bioavailability of gallic acid and monogalloyl glucose was evaluated in a 
porcine model and qualitatively compared to transport in the Caco-2 cell monolayer. 
Using buffered solutions of gallic acid and monogalloyl glucose administered orally and 
intravenously, absorption was estimated by monitoring concentrations of gallic acid and 
monogalloyl glucose and key phase II metabolites. The compounds 4-O-methylgallic 
acid and 4-O-methylgallic acid-3-O-sulfate were previously identified as the 
predominant metabolites following gallic acid consumption [65, 82], and therefore were 
monitored in porcine plasma over a 10 h period through surgically inserted blood-draw 
catheters in this study. As an internal standard, ethyl gallate was recovered at 90.9 ± 
0.23% across all samples. Non-compartmental pharmacokinetic analysis revealed the 
Cmax for gallic acid and monogalloyl glucose as 3.42 ± 1.07 mg/L and 0.13 ± 0.05 mg/L 
and an AUC of 3.57 ± 0.07 mg/L·h and 0.09 ± 0.03 mg/L·h, respectively (Table 5). 
Despite a similar absorption rate in the Caco-2 model, monogalloyl glucose was found to 
be significantly (p<0.05) less absorbed than gallic acid. Gallic acid was quickly cleared 
from porcine plasma with a half-life of 0.10 ± 0.04 h (6 min). In contrast monogalloyl 
glucose had a half-life of 0.34 ± 0.05 h (20 min), and the absolute bioavailability for 
gallic acid and monogalloyl glucose was found to be 19.3 ± 4.40% and 0.28 ± 0.20%, 
respectively. The rapid elimination of gallic acid and monogalloyl glucose from plasma 
is significantly higher when compared to other polyphenolics such as epigallocatechin 
gallate which when intravenously administered in rats was reported to have a half-life of 
51 min [143]. This suggests that gallic acid is more bioavailable than previously thought 
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and due to the short half-life any gallic acid that is absorbed will only be in circulation 
for a short time prior to renal excretion. Previous investigations that report the 
pharmacokinetics of gallic acid have only performed oral administration experiments 
which lacks data from intravenous administration needed to calculate absolute 
bioavailability, the relationship between oral absorption and intravenous clearance [84, 
144]. This work indicated that in a porcine model, gallic acid has an absolute 
bioavailability near 20%, and supports previous investigations where high amounts of 
free and metabolized forms of gallic acid are found in urine but with low concentrations 
in plasma [38, 55, 145, 146].  
Classic pharmacokinetic models, while useful in measuring the kinetics of the 
analyte of interest, do not take into consideration changes in analyte concentration due to 
phase II metabolism. Both gallic acid and monogalloyl glucose were converted to phase 
II metabolites with AUCs for gallic acid, 4-O-methylgallic acid, and 4-O-methylgallic 
acid-3-O-sulfate of 3.57 ± 0.07, 4.90 ± 1.30, and 7.86 ± 1.18 mg/L*h after oral 
administration of gallic acid and 2.73 ± 1.45, 5.08 ± 0.96, and 9.19 ± 2.38 mg/L*h after 
oral administration of monogalloyl glucose (Figure 16). Both gallic acid and 
monogalloyl glucose produced a similar concentration of gallic acid metabolites, but no 
methyl, sulfur, or glucuronide conjugates of monogalloyl glucose were detected. In 
context with their high bioaccessibility from mango fruit and Caco-2 transport, data 
suggest that monogalloyl glucose is absorbed in vivo but derived metabolites are not 
detected until deglycosylation occurs prior to being found in circulation, either in the 
intestines or liver. Monogalloyl glucose is the predominate polyphenol in several mango 
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Figure 16. Area under the curve (AUC) for the metabolites gallic acid, 4-O-methylgallic 
acid, and 4-O-methylgallic acid-3-O-sulfate after oral administration of gallic acid and 
monogalloyl glucose determined in a porcine model. 
 
 
 
varieties, and in the Ataulfo mango pulp analyzed in this study, it accounted for 35% of 
the total gallated polyphenolic content. The ability for monogalloyl glucose to have the 
same metabolic potential as free gallic acid is critical as the concentration differences 
between gallic acid and monogalloyl glucose among mango cultivars may not affect 
their bioefficacy.  
Unexpectedly, no metabolites sourced from pyrogallol were identified in porcine 
plasma after oral administration trials. Pyrogallol metabolites were previously reported 
in trials where gallic acid containing foods were orally administered in humans [38, 55]. 
The lack of pyrogallol metabolites in the porcine model indicates that either the majority 
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of gallic acid and monogalloyl were absorbed in the small intestine or were degraded 
due to prolonged exposure in digestion conditions as previously discussed in Section 4.2, 
leaving only a limited amount available for colonic metabolism. In summary, both gallic 
acid and monogalloyl glucose are bioaccessible from mango fruit preparations, able to 
be absorbed in the small intestine, and able to produce similar amounts of the phase II 
metabolites, 4-O-methylgallic acid and 4-O-methylgallic acid-3-O-sulfate. 
 
4.4 Conclusions  
The polyphenol composition of mango pulp is comprised primarily of galloyl 
derivatives. In this study, the galloyl derivatives monogalloyl glucose and gallic acid 
were found to be bioaccessible in both homogenized and cubed mango pulp and have the 
potential to be absorbed and metabolized. A significant amount of gallotannins remained 
bound within the food matrix for both homogenized and cubed mango suggesting 
limited bioaccessibility in the small intestine and will transit to the colon. For the first 
time gallic acid and monogalloyl glucose were shown to be transported across Caco-2 
monolayers at a similar rate. In a porcine model, similar amounts of phase II galloyl 
metabolites were found for gallic acid and monogalloyl glucose following oral 
administration, and this may suggest that the differences in composition of non-tannin 
galloyl derivatives between mango cultivars is not a major factor impacting the 
physiological production of gallic acid metabolites. 
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CHAPTER V 
A NOVEL PROTEIN PRECIPITATION METHOD FOR THE RECOVERY OF 
GALLIC ACID METABOLITES IN PLASMA 
 
5.1 Introduction 
An inverse correlation between cancer and cardiovascular disease with increased 
levels of fruit and vegetable consumption is well established in a number of meta-
analyses [17-20, 22]. This has largely been attributed to the phytochemical content of 
fruits and vegetables and specifically their polyphenols, secondary metabolites of all 
higher plants. Original hypotheses predicted the antioxidant properties of polyphenols 
were the source of their health promoting properties. However, numerous investigations 
report polyphenolics to have poor bioavailability, and any that are absorbed will undergo 
extensive xenobiotic metabolism or later experience catabolism by micro-organisms 
residing in the gastrointestinal tract that change their chemical properties [79]. This has 
led to the conclusion that the metabolites, not the precursors naturally found in fruits and 
vegetables, are likely a source of polyphenol’s health benefits. Current research efforts 
create profiles of the potential metabolites that may occur after consumption of specific 
foods, which can then be tested for bioefficacy [38, 66, 147]. 
LC-MS is the method of choice for analysis of polyphenol metabolites in 
biological matrices. However, sample preparation techniques for analysis of polyphenol 
metabolites contrast to that of their parent compounds present in fruits and vegetables 
due to conjugation with methyl, sulfate, and glucuronide functional groups from phase II 
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enzymes. Additionally, analyte concentrations are inherently low, often at the nM level, 
and are complicated by protein and other matrix characteristics of biological samples. 
Currently there is no standard method for isolating polyphenols from biological 
matrices, and as the chemistries of the analytes differ depending on the class of 
polyphenol being analyzed sample preparation methodologies may differ for each 
investigation [59, 61, 66, 100, 101]. The two most commonly reported methods for 
metabolite extraction utilize an organic solvent such as acetonitrile, methanol, or ethyl 
acetate or solid phase extraction (SPE) using various stationary phases with reversed 
phase the most common. Gallic acid is reported as one of the least recoverable 
polyphenolics in biological matrices likely due to its innate protein binding ability and 
hydrophilicity compared to other polyphenolics and these physicochemical properties 
make it difficult to extract with solvents or partition with SPE [148]. 
No reports are available on the extraction and recovery of gallic acid’s phase II 
metabolites from plasma, likely due to the lack of analytical standards. Metabolites may 
differ in extraction efficiency in relation to the parent compound with the addition of 
methyl and sulfur groups. For example, methylated epigallocatechin-gallates were found 
with enhanced plasma protein binding affinity compared to non-methylated forms [102]. 
In this study, a new method for extraction of gallic acid metabolites from plasma is 
described utilizing sodium dodecyl sulfate (SDS) as a protein denaturant and was 
evaluated against current state of the art methods in literature. The method was 
subsequently applied to an acute mango feeding trial with 10 subjects to investigate the 
pharmacokinetics of mango galloyl metabolites. 
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5.2 Materials and Methods 
5.2.1 Chemicals and Supplies 
Authentic standards for gallic acid, pyrogallol, and ethyl gallate were acquired 
from Sigma Aldrich (St Louis, MO). 4-O-methylgallic acid was acquired from Apin 
Chemicals (Oxfard, UK). Methanol, acetonitrile, and 88% formic acid were acquired 
from Thermo Fisher Scientific (Waltham, MA). HLB columns (100 mg) were acquired 
from Waters Corp. (Milford, MA). Prepared solvents for HPLC made of 0.1% formic 
acid water and 0.1% formic acid methanol were acquired from Sigma Aldrich, and 3M 
KCl solution was from Thermo Fisher Scientific. 
 
5.2.2 SDS Plasma Precipitation  
Recovery of pyrogallol, gallic acid, 4-O-methylgallic acid, and ethyl gallate in 
human plasma was performed by taking 475 μL of plasma acidified with 25 μL of 88% 
formic acid and mixing 50 μL of a standard solution containing pyrogallol, gallic acid, 4-
O-methylgallic acid, and ethyl gallate in 1.5 mL Eppendorf tubes. Proteins were 
precipitated by adding 75 μL of 10% SDS and tubes gently mixed to ensure adequate 
binding to plasma albumins. Lastly, 400 μL of methanol acidified with 0.1% formic acid 
was added and tubes vigorously vortexed for 20 seconds followed by sonication in a 
Branson 3510 sonicator (Danbury, CT) for 10 minutes. Tubes were centrifuged at 10,000 
x g for 5 min at 4 ºC and excess SDS in the supernatant removed by centrifugation after 
the addition of 50 μL of 3 M KCl. Samples were held at 4 ºC for 1 h prior to analysis. 
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5.2.3 Method Evaluation 
The use of SDS to precipitate plasma proteins was evaluated for extraction 
recovery, matrix effect, and inter-day precision across three concentrations (50, 250, and 
500 μg/L).  Extraction recovery was calculated from polyphenolic-free plasma spiked 
with standard solutions and compared to aqueous standards under identical conditions. 
The matrix effect from plasma was calculated by recovery from SDS precipitated plasma 
spiked with standard solutions and compared to an aqueous standard of the same 
concentration. Inter-day precision was calculated from coefficient of variation between 
extractions of spiked standards performed across three different days. The limit of 
detection (LOD) and limit of quantification (LOQ) were found using aqueous standards 
and defined as the signal to noise ratio of 3/1 and signal to noise ratio of 5/1, 
respectively. 
 
5.2.4 Plasma Extraction Comparisons 
Two commonly reported methods to extract or concentrate polyphenolic 
metabolites from blood plasma are solvent precipitation with acetonitrile and SPE with 
reversed phase chemistry. Methods were based off prior studies that reported high 
recoveries of gallic acid [61, 99]. Polyphenol-free human plasma (200 µL) was spiked 
with 50 µl of a mixture containing standards of pyrogallol, gallic acid, 4-methylgallic 
acid, and ethyl gallate. Plasma was acidified to denature proteins with 800 µL of 0.1 % 
formic acid in acetonitrile added dropwise, sonicated for 10 minutes, centrifuged at 
10,000 x g, and dried under vacuum at 65 °C in a Thermo Fisher SpeedVac. The extract 
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was reconstituted in 200 µL of 1:1 methanol and water containing 0.1% formic acid for 
HPLC-MS analysis. For solid-phase extraction, a 100 mg Waters Oasis® HLB cartridge 
was activated with 10 column volumes of methanol with 0.1% formic acid followed by 
10 column volumes of water with 0.1% formic acid using a vacuum manifold. 
Polyphenolic-free plasma (500 µL) was diluted with 1,500 µL of water with 0.1% 
formic acid and dropwise passed through the column. The column was washed with 2 
column volumes of acidified water and polyphenolics eluted with 2,000 µL of acidified 
methanol and evaporated to dryness under vacuum. Isolates were reconstituted into 200 
µL of 1:1 methanol and water containing 0.1% formic acid for HPLC-MS analysis.  
 
5.2.5 LC-MS Analysis 
Spiked standards and phase II metabolites of gallic acid and pyrogallol were 
characterized and quantified using a Thermo Finnigan LCQ Deca XP Max MSn ion trap 
mass spectrometer equipped with an ESI source in TurboScan Mode. Separations were 
in reversed-phase using a Finnigan Surveyor HPLC coupled to a Surveyor PDA detector 
and gradient separations were performed using a Phenomenex Kintex™ (Bannockburn, 
Il) C18 column, (150 x 4.6 mm, 2.6 µm) at room temperature. Injections were made into 
the column by use of a 50 μL sample loop. For separation of galloyl metabolites mobile 
phase A was 0.1% formic acid in water and mobile phase B was 0.1% formic acid in 
methanol run at 400 μL/min. A gradient was run of 0% Phase B for 5 min and changed 
to 5% Phase B in 10 min, 5 to 10% Phase B in 15 min, 10 to 20% Phase B in 25 min, 
and 20% to 80% Phase B in 35 min, and 80% Phase B was held to 39 min before 
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returning to initial conditions. MS analysis began 10 min into the run for quantifications 
and selected reaction monitoring (SRM) for characterization of metabolites in the 
absence of authentic standards. The electrospray interface worked in negative ionization 
mode tuned for 4-O-methylgallic acid with source and capillary temperatures set at 
325°C, source voltage at 4.0 kV, capillary voltage at -47 V, and collision energy for 
MS/MS analysis at 35 eV. The instrument operated with sheath gas and auxiliary gas 
(N2) flow rates set at 8 units/min and 0 units/min, respectively. All samples from a 
subject were run during the same set of runs. Following a set of runs the column was 
washed with 80:20 acetonitrile and methanol with 0.1% formic acid at 400 μL/min for 1 
h. 
 
5.2.6 Pharmacokinetics of Mango Gallic Acid Phenolics  
Ten healthy human volunteers (aged 21-39) with no history of chronic diseases 
or digestive disorders were recruited for a mango consumption trial. Mature, unripened 
mangos (cv. Ataulfo) sourced from Mexico were imported by Frontera Produce 
(Edinburg, TX) and the National Mango Board, and shipped refrigerated to the 
Department of Nutrition and Food Science at Texas A&M University. Fruit were 
allowed to ripen under ambient conditions, and fruit that exhibited uniform ripeness, 
based on skin color and manual texture determination, were manually peeled, deseeded, 
cubed, and stored at -20°C in vacuum sealed bags under Good Manufacturing Practices. 
Participants were asked to refrain from high polyphenolic foods and especially 
gallic acid containing foods such as berries, grapes, tea, and wine and filled out a 72 h 
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food survey prior to the study. After an overnight fast a baseline blood sample was 
collected into tubes containing EDTA then centrifuged at 3,000 x g for 5 min at 4°C. 
Participants then consumed 400 g of cubed mango pulp, and blood samples collected 
through a blood catheter at 0.5, 1, 1.5, 2, 3, 4, 6, and 8 h. Plasma was aliquoted and 
acidified with 20 μL of 88% formic acid for every 500 μL of plasma, and held at -80°C. 
This study was approved by the Institutional Review Board (IRB) at Texas A&M 
University.  
 
5.2.7 In Vivo Method Comparison 
The ability of the SDS protein precipitation method to extract gallic acid and 
pyrogallol phase II metabolites was compared against the acetonitrile and SPE extraction 
methods. Plasma samples from the pharmacokinetics trial were pooled from 2 and 8 h 
post prandial and were extracted in triplicate with the SDS protein precipitation method, 
acetonitrile precipitation, and SPE with HLB chemistry outlined in the Method 
Comparison Section. 
 
5.2.8 Statistics 
Trials for method development were performed in triplicate in individual reaction 
vessels. All statistics were performed by the use of SigmaPlot 12.5. Significant 
differences were found by use of Student t-test. All results are reported as mean ± 
standard error of the mean. Non-compartmental pharmacokinetics were calculated using 
PkSolver previously developed by Zhang et al. (2010) with area under the curve being 
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calculated by the linear trapezoidal method [132]. The sample sizes for calculation of 
phase II metabolites standard error of the mean were the number of subjects with 
quantifiable amounts of metabolites. 
 
5.3 Results and Discussion 
5.3.1 SDS Plasma Precipitation 
The ability of SDS to precipitate human plasma proteins and disrupt polyphenol-
protein interactions for the analysis of pyrogallol, gallic acid, 4-O-methylgallic acid, and 
ethyl gallate was investigated. SDS is commonly used as a protein denaturant in SDS-
PAGE applications, and has previously been demonstrated to separate tannin and protein 
complexes in numerous reports [149-151]. SDS is unique in its mechanism of protein 
precipitation as it unfolds proteins into their primary structure as opposed to solvent 
precipitation which denatures proteins by refolding amino acid side chains into a 
different tertiary structure [152]. Recovery from and matrix interactions in human 
plasma were determined by spiking polyphenolic-free human plasma with authentic 
standards of pyrogallol, gallic acid, 4-O-methylgallic acid, and ethyl gallate. LC-MS 
analysis allowed for detection of targeted analytes in aqueous solutions with a LOD for 
pyrogallol, gallic acid, 4-O-methylgallic acid, and ethyl gallate at 31.3, 3.90, 15.6, and 
1.95 µg/L and LOQ at 62.5, 7.80, 31.3, and 3.90 μg/L, respectively. Gallic acid had the 
poorest recovery using SDS for protein precipitation at 79.6 ± 1.6, 79.9 ± 3.84, and 78.9 
± 4.10 % at, 50, 250, and 500 µg/L, respectively (Table 6). Recovery of 4-O-
methylgallic acid and ethyl gallate exceeded 82% at all concentrations evaluated. 
 74 
 
Table 6. Extraction recoveries, matrix effect, and inter-day precision of gallic acid metabolites (pyrogallol, gallic acid, 4-O-
methylgallic acid, and ethyl gallate) in human plasma using sodium dodecyl sulfate at three concentrations (50, 250, and 500 
µg/L).  
Analytes 
Concentration 
(µg/L) 
 
 
Recovery1 
 
Matrix 
Effect2 
 
Inter-Day 
Precision (CV%)3 
pyrogallol 50  ND
4 ND ND 
 250  ND ND ND 
 500  85.1 ± 5.0 0.85 10.2 
     
gallic acid 50  79.6 ± 4.67 0.79 10.2 
 250  79.9 ± 3.84 0.86 8.33 
 500  78.9 ± 4.10 0.84 9.01 
     
4-O-methylgallic acid 50  89.3 ± 5.97 0.89 11.57 
 250  88.9 ± 6.79 0.89 13.24 
 500  93.1 ± 5.10 1.10 9.50 
     
ethyl gallate 50  102.9 ± 8.39 1.17 14.1 
 250  93.1 ± 3.69 0.97 6.87 
 500  82.4 ± 1.93 0.84 4.05 
     
1. Recovery calculated as the ratio of analyte concentration spiked in plasma prior to extraction to a known standard with 
results reported as percent recovered ± standard error of the mean. 
2. Calculated as the ratio of spiked analyte post extraction to a known standard. 
3. Inter-Day Precision is expressed as the coefficient of variation between extractions of spiked plasma in triplicate on three 
different days.  
4. ND, not detected. 
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Matrix effect is defined as the change in the ability of an analyte to ionize under 
electrospray ionization conditions due to co-eluting compounds from a complex sample 
matrix, and has been previously reviewed by Gleichenhagan and Schieber to be a current 
challenge in polyphenol analytical chemistry [80]. Using the SDS protein precipitation 
method, gallic acid had a fixed decrease in ion efficiency due to the plasma matrix with a 
decrease in ionization of 14 to 21%, which would cause an underrepresentation of actual 
concentrations. This was confirmed when the extracted ion chromatograms were 
compared to the chromatograms at 280 nm. A measurement of peak heights at 280 nm 
showed gallic acid recoveries were greater than 80% across all three concentrations. 
While the PDA can be used to quantify standards its application is limited in the analysis 
of unknown targets. 4-O-methyl gallic acid and ethyl gallate matrix effects were varied 
ranging from -11 to 10% and -15 to 17%, respectively. The coefficients of variation for 
inter-day precision was < 15% for all compounds and concentrations. Guidelines from 
the FDA regarding bioanalytical method development define <15% as acceptable [153].  
Pyrogallol had an extraction recovery of 85.1 ± 5.0% at 500 μg/L, however, it 
was not able to be detected at lower concentrations. Free pyrogallol is known to be very 
unstable due to rapid reaction with oxygen and combined with concentrations near its 
LOD and a decrease in ionization efficiency by 15% due to the matrix effect for this 
compound made it difficult to recover [154]. 
In the method development for SDS plasma protein precipitation, it was found 
that plasma proteins only precipitated when plasma was acidified, and it was critical to 
remove excess SDS due to the known interferences with reverse phase chromatography 
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and ion suppression with an ESI source [155]. A simple solution was the addition of 
saturated KCl as a cationic counter-ion that adequately precipitated residual SDS. When 
samples were injected without the addition of KCl, the ability to ionize was substantially 
inhibited. Additionally, when SDS was applied in small increments 3 x 25 μL 10% SDS 
vs 75 μL of 10% SDS all at once, no significant (p<0.05) differences were found in the 
recovery of spiked standards which allowed for rapid processing of samples. This trait 
makes the SDS protein precipitation method a faster alternative to contemporary 
methods that rely on concentration steps. SDS protein precipitation was successful in 
recovering gallic acid and 4-O-methylgallic acid from human plasma and has the 
potential to be applied in the recovery of other polyphenols that may experience protein-
polyphenol interactions. 
 
5.3.2 Method Comparisons 
The recovery of polyphenolic standards using SDS protein precipitation was 
compared to recoveries using more widely employed methods of acetonitrile protein 
precipitation and SPE with Waters Oasis HLB cartridges using spiked polyphenolic-free 
plasma at 500 μg/L. SDS protein precipitation was found to have a significantly (p<0.05) 
higher amount of recoverable polyphenolics compared to both acetonitrile and SPE. 
Extraction with SPE had the least amount of recoverable standards with extraction 
recoveries of 19.1 ± 3.41, 14.5 ± 3.74, 17.3 ± 6.78, and 6.46 ± 1.08% for pyrogallol, 
gallic acid, 4-O-methylgallic acid, and ethyl gallate respectively (Figure 17). Gasperotti 
et al. previously observed reverse phase SPE to be less efficient in retention of gallic 
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acid due to its polarity with a recovery of 53% in plasma while relatively more non-polar 
phenolics such as sinapic acid and coumaric acid had recoveries of over 87% [156]. 
Recovery of pyrogallol, gallic acid, 4-O-methylgallic acid, and ethyl gallate from 
 
 
Figure 17. Comparison in extraction recoveries of pyrogallol (PG), gallic acid (GA), 4-
O-methylgallic acid (MG), and ethyl gallate (EG) using precipitation with acetonitrile 
(ACN), SDS protein precipitation method (SDS), and solid phase extraction using 
Waters HLB cartridges (HLB) all at 500 μg/L. Different letters for each analyte denote a 
significant difference in recovery based on extraction method (p< 0.05). 
 
 
 
plasma using acetonitrile precipitation was similarly low at 29.0 ± 1.20, 37.1 ± 9.04, 
23.4 ± 10.1%, and 58.7 ± 3.72% for pyrogallol, gallic acid, 4-O-methylgallic acid, and 
ethyl gallate, respectively.  Using the same ratio of plasma to acetonitrile, Ma et al. 
previously reported acetonitrile to isolate gallic acid with recoveries of 78-86% from 30-
3000 μg/L, however such an efficient recovery was not replicated in this study [99]. 
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Protein precipitation with solvent and SPE are the most cited methods to extract 
polyphenols from human plasma, yet the studies that have evaluated gallic acid report 
spiked concentrations ranging from 0.02 mg/L to 500 mg/L, with the later concentrations 
far higher than would be expected in plasma even with dietary supplementation [61, 98, 
156]. 
 
5.3.3 Pharmacokinetics of Galloyl Metabolites 
The use of SDS to rapidly denature serum proteins and extract polyphenolic 
metabolites was evaluated for its application in a human clinical trial, and the 
pharmacokinetics of gallic acid and galloyl glycoside phase II metabolites from acute 
mango consumption was evaluated from blood samples collected over an 8 h period. 
Both gallic acid and monogalloyl glucose were previously reported to be absorbed in the 
small intestine of humans and metabolized to produce 4-O-methylgallic acid and 4-O-
methylgallic acid-3-O-sulfate in urine [74, 82]. Galloyl derivatives not absorbed in the 
small intestine are catabolized by microorganisms in the colon and converted to 
pyrogallol or even further into catechol that can be absorbed and also undergo phase II 
metabolism [38, 55]. The pro-gallic acid content of the mango pulp used in this study 
was previously reported in Chapter IV to contain 259 mg of total galloyl derivatives per 
400 g of pulp that included 3.64 mg of free gallic acid, 91.7 mg of monogalloyl glucose, 
and 164 mg of gallotannins that ranged in degree of polymerization from 5 to 10 galloyl 
units.  
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Table 7. Characterization and pharmacokinetic parameters of gallic acid metabolites following human consumption of 400 g 
of mango pulp (cv. Ataulfo).  
 
Metabolites 
[M-H]- 
(m/z) 
MS/MS 
(m/z) 
Tmax 
(h) 
Cmax 
(μg/L) 
AUC0-8h 
(μg/L·h) 
Subjects1 
(n) 
pyrogallol-O-sulfate 205 125 6 1,325 ± 437 5,990 ± 1,6905 9 
catechol-O-sulfate 189 109 8 3,362 ± 1380 9,520 ± 3,360 10 
methylpyrogallol-O-sulfate 219 205, 125 8 971 ± 391 4,020 ± 1,040 7 
4-O-methylgallic acid-3-O-sulfate 263 183, 169 2 1,546 ± 291 6,030 ± 1,310 10 
4-O-methylgallic acid 183 169, 125 1.5 611 ± 189 2,790 ± 1,190 7 
1. The number of subjects whose plasma had quantifiable amounts of each metabolite. 
2. Reported as the average concentration ± the standard error of the mean. 
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Figure 18. Pharmacokinetics of 4-O-methylgallic acid (MG), 4-O-methylgallic acid-3-
O-sulfate (MGS), following tentative characterization and semi-quantification in human 
plasma after consumption of 400 g of mango pulp (cv. Ataulfo) in healthy volunteers. 
Data represent the average and standard error of the mean (n=10).  
 
 
 
 Five plasma metabolites sourced from gallic acid and galloyl glycosides were 
characterized based on fragmentation patterns previously reported, and semi-quantified 
using the SDS protein precipitation method (Table 7) (Figure 18) (Figure 19) [65, 82]. 
Average recovery of ethyl gallate as an internal standard across all samples (n=88) from 
all subjects was 87.7 ± 1.23%. Two metabolites with a base structure of gallic acid were 
characterized as 4-O-methylgallic acid and 4-O-methylgallic acid-3-O-sulfate. 4-O-
methylgallic acid was compared to an authentic standard for retention time and its parent 
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ion at m/z 183 and MS/MS fragment ion at m/z 169. Likewise, 4-O-methylgallic acid-3-
O-sulfate had a parent ion at m/z 263 that produced two major MS/MS fragment ions of  
m/z 183 and 169, which represented methylgallic acid and gallic acid respectively. Both 
4-O-methylgallic acid and 4-O-methylgallic acid-3-O-sulfate had peak plasma 
concentrations within 2 h at a Cmax of 611 ± 189 μg/L and 1,550 ± 291 μg/L, and AUC0-
8h of 2,780 ± 1,190 and 6,030 ± 1,310 μg/L·h, respectively. Free gallic acid was not 
found in any plasma samples in agreement with Pimpão et al. who fed 425 mg of free 
gallic acid from a mixed berry puree that contained, blueberries, blackberries, 
raspberries, and strawberries [55].  
 
 
Figure 19. Pharmacokinetics of pyrogallol-O-sulfate (PGS), methylpyrogallol-O-sulfate 
(MPGS), and catechol-O-sulfate (CS) following tentative characterization and semi-
quantification in human plasma after consumption of 400 g of mango pulp (cv. Ataulfo) 
in healthy volunteers. Data represent the average and standard error of the mean (n=10). 
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Three metabolites were generated from decarboxylated gallic acid in the GI tract 
and were tentatively identified as pyrogallol-O-sulfate, methylpyrogallol-O-sulfate, and 
catechol-O-sulfate. Pyrogallol-O-sulfate and catechol-O-sulfate were characterized 
based on their respective predominant parent ions at m/z 205 and 189 and fragment ions 
at m/z 125 and 109, which represent pyrogallol and catechol, respectively. Both 
produced neutral loss fragments of 80 Da corresponding to the losses of sulfate groups. 
Methylpyrogallol-O-sulfate had a parent ion of m/z 219 and produced fragment ions at 
m/z 205 and 125, which represented fragments of pyrogallol-O-sulfate and pyrogallol. 
The three metabolites had a Tmax from 6 to 8 h postprandial, and Cmax of 1,330 ± 437, 
971 ± 391, and 3,360 ± 1,380 μg/L and AUC0-8h of 5,990 ± 1,690, 4,020 ± 1,040, and 
9,520 ± 3,360 μg/L·h for pyrogallol-O-sulfate, methylpyrogallol-O-sulfate, and catechol-
O-sulfate, respectively. Free pyrogallol and catechol were not found in any plasma 
isolates, it is possible that the body is adept at metabolizing and clearing these 
xenobiotics, however, as concentrations below 500 μg/L could not be recovered in the 
method development it is possible they were not detected. Absorption of pyrogallol and 
catechol from the colon was still occurring after 8 h indicating long-term production of 
key metabolites from mango consumption (Figure 19). A study by Van der Pijl  et al. 
reported finding plasma pyrogallol metabolites from black tea 30 h after a single 
consumption [84]. Given the extended period at which polyphenol metabolites sourced 
from colon can be detected in plasma they could be useful biomarkers for fruit and 
vegetable intake, and are critical to properly assay in order to investigate their bioactive 
responses in vivo.   
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All metabolites were reported to have high coefficients of variation ranging from 
69 to 113%. While this is not uncommon for polyphenol pharmacokinetic studies, 
mango in particular has an additional factor that can increase the variation of subjects’ 
ability to produce gallic acid metabolites, the gallotannins. Gallotannins can freely 
hydrolyze to gallic acid under physiological conditions, and are also capable of 
undergoing hydrolysis by colonic bacteria such as Lactobacillus plantarum and 
Streptococcus galloylticus because of their ability to produce tannase, an enzyme 
capable of hydrolyzing m-depside bonds [115, 137]. However, due to the large 
differences in gut bacteria populations per person it is unlikely each person has similar 
potential to break down gallotannins. As such there will be a large inter-person variation 
in the amount of gallic acid that can be produced in the colon.  
 
5.3.4 In Vivo Method Comparison 
For additional conformation that the SDS protein precipitation method was more 
efficient than acetonitrile denaturation and SPE at recovering gallic acid and pyrogallol 
phase II metabolites were extracted from a pool of plasma at 2 and 8 h, the Tmax of the 
respective metabolites (Table 8). Significantly (p<0.05) more 4-O-methlgallic acid, 4-O-
methlgallic acid-3-O-sulfate, and catechol-O-sulfate were recovered using the SDS 
protein precipitation method with concentrations of 842 ± 39.2, 2,570 ± 90.9, 1,880 ± 
4.96 μg/L respectively. A non-significant increase was observed using SDS for 
methylpyrogallol-O-sulfate in comparison to acetonitrile with concentrations of 741 ± 
125 and 415 ± 88.3 μg/L, respectively. The remaining concentrations of 4-O- 
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Table 8. Comparison of gallic acid and pyrogallol phase II metabolite plasma concentrations from pooled plasma using SDS 
protein precipitation method (SDS), acetonitrile protein precipitation (ACN), and solid phase extraction with HLB chemistry 
(HLB). 
 2 h1   8 h  
 4-O-methylgallic 
acid 
4-O-methylgallic 
acid-3-O-sulfate 
 methylpyrogallol-O-
sulfate 
catechol-O-
sulfate 
SDS 842 ± 39.2a,2 2570 ± 90.9a  741 ± 125a 1880 ± 4.96a 
ACN 336 ± 51.7b 509 ± 182b  415 ± 88.3a 587 ± 99.8b 
HLB 119 ± 7.06c NDc  45 ± 44.5b NDc 
1. Time points used for pooled plasma samples that were the Tmax for the respective metabolites. 
2. Different letters for each analyte denote a significant (p<0.05) difference in concentration based on extraction method with 
concentration reported as the average ± the standard error of the mean. 
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methylgallic acid, 4-O-methlgallic acid-3-O-sulfate, and catechol-O-sulfate following 
extraction with acetonitrile were 336 ± 51.7, 509 ± 182, and 587, ± 99.8 μg/L, 
respectively. The lowest concentrations of recovered phase II metabolites were observed 
following extraction with SPE at 119 ± 7.06 and 45 ± 44.5 μg/L for 4-O-methlgallic acid 
and methylpyrogallol-O-sulfate. 4-O-methlgallic acid-3-O-sulfate and catechol-O-sulfate 
were not detected with SPE. Pyrogallol-O-sulfate was not detected in any of the 
extractions from the pooled plasma. 
 
5.4 Conclusions 
In conclusion, a novel protein precipitation method utilizing SDS was developed 
for improved recovery of gallic acid from human plasma. The SDS denaturation protocol 
was utilized to extract human plasma for gallic acid metabolites generated after an acute 
feeding of 400 g of fresh mango pulp. Five metabolites, two from gallic acid and three 
from pyrogallol were characterized and semi-quantified over an 8 h period. The SDS 
method was proven to be able to extract significantly more gallic acid metabolites from 
plasma compared to current methods reported in the literature. Plasma extraction of 
gallic acid and its metabolites with SDS is a simple and rapid method that has potential 
to be applied in the analysis of other polyphenolic analytes.  
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CHAPTER VI 
DAILY CONSUMPTION OF MANGO CV. ATAULFO FOR 42 DAYS AND ITS 
INFLUENCE ON THE METABOLISM AND EXCRETION OF GALLIC ACID, 
GALLOYL GLYCOSIDES, AND GALLOTANNINS 
 
6.1 Introduction 
Mangos are one of the most important fruit crops in the world ranking behind 
only grapes, apples, and bananas in global production [48]. Mango’s pulp, peel, and seed 
is consumed all over the globe and the fruit is widely considered as a good source of 
many essential nutrients including vitamin C, pro-vitamin A, and dietary fiber. All parts 
of the mango additionally contain polyphenolics, predominantly galloyl derivatives 
including free gallic acid, gallic acid glycosides, and gallotannins. Polyphenolic extracts 
from mango have been reported to have anti-cancer and anti-inflammatory properties in 
vitro and in animal models [125, 157, 158], and in an obese human subject trial 
participants that consumed freeze-dried mango pulp for 12 wks had improved fasting 
blood glucose levels [159]. Recent findings however have demonstrated that 
polyphenolics undergo extensive biotransformation during digestion potentially negating 
previous hypotheses that suggested the health promoting properties of polyphenols were 
due to the un-metabolized parent compounds found in the fruit [16, 112, 160]. Present 
studies have focused on characterizing metabolites formed during digestion from each 
individual polyphenolic, gallic acid was previously reported to be absorbed from the 
small intestine and metabolized in the liver where the endogenous phase II enzymes 
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catechol-O-methyltransferase and sulfotransferases conjugate it to predominantly 
produce 4-O-methylgallic acid and 4-O-methylgallic acid-3-O-sulfate [38]. Gallic acid 
not absorbed will transit to the colon where it is catabolized by host bacteria to produce 
smaller phenols such as pyrogallol and catechol that are likewise absorbed and 
metabolized by the host [55, 82]. Monogalloyl glucose was found to have the same 
metabolic potential as gallic acid, as previously discussed in Chapter IV. Oligomeric 
galloyl glucoses and gallotannins however are too large to be absorbed intact in the 
small intestine and must be depolymerized by hydrolytic esterases residing in the 
gastrointestinal tract or through non-enzymatic hydrolysis to generate bioaccessible 
gallic acid [71, 107]. Thus, mango pulp is a source of several pro-gallic acid compounds 
with the potential to produce galloyl and pyrogallol metabolites. 
Several studies have proposed the influence of long-term polyphenol intake on 
reducing inflammatory biomarkers and cancer rates [17, 19, 21, 87]. Current hypotheses 
propose that the mechanisms behind the health benefits of polyphenols are linked to their 
concentrations in tissues and plasma [161-163]. Conversely only a limited amount of 
reports are available that have evaluated plasma concentrations of phenolic metabolites 
after repetitive dietary intake, and results from these trials can be conflicting depending 
on the class of polyphenolic consumed. For example, repeated feeding of grape seed 
extract to rats for 10-days resulted in a 395% increase in gallic acid concentrations in 
plasma [92]. In contrast, humans that consumed 400 mg of green tea polyphenols daily 
for 4 weeks had no significant difference in the plasma concentrations of 
epigallocatechin-gallate but when the dose was increased to 800 mg a 60% increase was 
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observed [93]. And in the daily consumption of freeze-dried blueberry powder for 30 
days with a total of 604 mg of total polyphenols consumed per day no significant 
changes were observed in their 24 h urinary excretion [164]. As such, the literature 
suggests that the bioavailability of polyphenolics following repetitive consumption can 
be different for each class of polyphenolics consumed. 
Previously we have observed significant increases in the urinary excretion of 
pyrogallol-O-sulfate and catechol-O-sulfate, metabolites sourced from break down of 
gallic acid in the colon, when 400 g of mango (cv. Keitt) was consumed daily for 10 
days [146]. This increase in metabolism was hypothesized to be due to changes in the 
composition of the subjects’ gut microbiota, and recently repetitive mango intake in rats 
was shown to promote the growth of Bifidobacteria bacteria [165-167]. Currently, the 
metabolic fate of galloyl glycosides and gallotannins in plasma following repetitive 
consumption is currently unknown. Therefore, the aim of this work was to investigate 
the effects of daily mango consumption for 42 days on the metabolism and excretion of 
mango pro-gallic acid compounds in Lean and Obese subjects with increases in 
bioavailability hypothesized to be due to increased colonic metabolism. 
 
6.2 Materials and Methods 
6.2.1 Mango Fruit 
Mature, green mangos (cv. Ataulfo) from Mexico were imported through 
Frontera Produce (Edinburg, TX), shipped to Texas A&M Department of Nutrition and 
Food Science, and allowed to ripen under ambient conditions. Mangos were deseeded, 
 89 
 
pulp removed from the skin, and vacuum sealed in 400 g bags under Good 
Manufacturing Practices. Mango pulp was frozen within 2 h of processing and stored at  
-20 ºC until use. 
 
6.2.2 Chemicals 
Standards of ethyl gallate, gallic acid, and pyrogallol were acquired from Sigma 
Aldrich (St Louis, MO) and 4-O-methylgallic acid from Apin Chemicals (Oxfard, UK). 
Water and methanol containing 0.1% formic acid were acquired from Sigma Aldrich (St 
Louis, MO) as well as a 10% solution of SDS.  
 
6.2.3 Experimental Design and Sample Processing 
Healthy volunteers (n = 32, aged 18 -50) with no medical history of digestive 
disorders participated in a 42 day mango consumption study divided into three cohorts. 
The Control cohort (n=11) consumed 400 g of mango pulp only on Days 1 and 42. The 
remaining two cohorts consumed 400 g mango pulp daily for 42 days and were divided 
into Lean and Obese groups. The Lean cohort (n=12) had a BMI from 18-25 and the 
Obese cohort (n= 9) had a BMI > 30. Three days prior to when the study began subjects 
refrained from consuming foods known to contain gallic acid or pro-gallic acid 
polyphenolics including mango, grape products, tea, chocolate, and berries. Baseline 
urine samples were collected prior to mango consumption and post-prandial from 0-3, 3-
6, 6-9, 9-12, and 12-24 h and on study Days 1 and 42. The volume of urine output was 
measured for each collection, and 12 mL acidified with 0.1 mL of 88% formic acid and 
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passed through a 0.45 μm filter for metabolite analysis by LC-MS. Baseline blood 
samples were collected prior to mango consumption, and post-prandial at 0.5, 1, 1.5, 2, 
3, 4, 6, and 8 h through a blood-draw catheter on Days 1 and 42. Blood samples were 
centrifuged at 3,000 x g for 5 min, and plasma acidified with 25 μL of formic acid. 
Plasma samples were stored at -80 °C until processed using the method previously 
described in Chapter V. Briefly, 50 μL of  an internal standard, ethyl gallate, was 
incubated with 500 μL of acidified plasma and 75 μL of 10% SDS was then added to 
denature proteins followed by addition of 400 μL of 0.1% formic acid methanol. Plasma 
was sonicated for 10 min, centrifuged for 5 min at 10,000 x g, and spiked with 50 μL of 
saturated KCl to remove residual SDS. Samples were held at 4 ºC for 1 h prior to being 
filtered through a 0.45 μm filter prior to LC-MS analysis. The study protocol was 
approved by the Institutional Review Board (IRB) of Texas A&M University. 
 
6.2.4 LC-MS Analysis 
Metabolites from galloyl derivatives were analyzed on a Thermo Finnigan 
Surveyor LCQ Deca XP Max MSn ion trap mass spectrometer equipped with an ESI 
source. Separations were in reversed-phase using a Thermo Finnigan Surveyor HPLC 
coupled to a Surveyor PDA detector and gradient separations were performed using a 
Phenomenex Kinetex™ (Bannockburn, Ill) C18 column (150 x 4.6 mm, 2.6 µm) at room 
temperature. Injections were made into the column by use of a 50 µL sample loop.  For 
separation of urine metabolites mobile phase A was 0.1% formic acid in water and 
mobile phase B was 0.1% formic acid in methanol run at 0.4 mL/min. A gradient was 
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run of 0% Phase B for 2 min and changed to 10% Phase B in 4 min, 10 to 15% Phase B 
in 8.5 min, 15% to 27% Phase B in 11 min, 27% to 90% Phase B in 15 min, 90% was 
held to 0.5 min before returning to initial conditions. For separation of plasma 
metabolites mobile phase A was 0.1% formic acid in water and mobile phase B was 
0.1% formic acid in methanol run at 0.45 mL/min. A gradient was run of 0% Phase B for 
2 min and changed to 10% Phase B in 4 min, 10% Phase B was held to 10 min, 10 to 
40% Phase B in 25 min, and 40% to 65% Phase B in 35 min, 65% to 85% Phase B in 41 
min, 85% was held to 49 min before returning to initial conditions. The electrospray 
interface worked in negative ionization mode. Source and capillary temperatures were 
set at 325°C, source voltage was 4.0 kV, capillary voltage was set at -47 V, and collision 
energy for MS/MS analysis was set at 35 eV. The instrument operated with sheath gas 
and auxiliary gas (N2) flow rates set at 10 units/min and 5 units/min, respectively. The 
instrument was tuned for 4-O-methylgallic acid and metabolites quantified using 
extracted ion chromatograms from their respective parent compounds as standards. 
 
6.2.5 Statistical Analyses 
Significant differences for metabolites in urine were calculated from the sum of 
their excretions over 24 h using students t-test in Sigma Plot software (SPSS, Chicago, 
IL). Significant differences between cohorts were calculated by using ANOVA. Non-
compartmental pharmacokinetic analysis was performed by use of the PkSolver 
Microsoft Excel Add-In [132]. Results are reported at the mean ± standard error of the 
mean. 
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6.3 Results and Discussion 
The pulp of the Ataulfo mango is known for its relatively high concentrations of 
gallic acid glycosides and gallotannins compared to other mango varieties. The 400 g of 
pulp fed to subjects contained a total of 259 mg of galloyl derivatives of which 95.4 mg 
were non-tannin, including gallic acid (3.64 mg) and monogalloyl glucose (91.7 mg), 
and the remaining 164 mg were gallotannins ranging in degree of polymerization from 
5-10 galloyl groups. Mango pulp contains a majority of pro-gallic acid polyphenolics 
and they can comprise over 50% of the total phytochemicals present [11]. 
 
6.3.1 Urinary Excretion Following 42 Days of Daily Mango Consumption 
The urinary excretion of phase II metabolites derived from galloyl derivatives 
following consumption of 400 g of Ataulfo mango pulp was evaluated in Lean and 
Obese subjects who consumed mango daily for 42 days and compared to a Control 
cohort that only consumed mango on Days 1 and 42. Seven gallic acid and pyrogallol 
based phase II metabolites were tentatively identified in the urine from m/z previously 
reported [65, 82] (Figure 20) (Table 9).  
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Figure 20. Tentative chemical structures of phase II metabolites following consumption 
of gallic acid, galloyl glycosides, and gallotannins sourced from 400 g of mango cv. 
(Ataulfo) pulp. 
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Table 9. Metabolites characterized and quantified in the plasma and urine of subjects who consumed 400 g of mango cv. 
Ataulfo pulp daily for 42 days.  
Metabolite Abv [M-H]- MS/MS Urine Plasma 
gallic acid GA 169 125  Trace1  ND2 
4-O-methylgallic acid MG 183 169, 125 Trace  +3 
4-O-methylgallic acid-3-O-sulfate MGS 263 183, 169 + + 
pyrogallol PG 125 - ND ND 
pyrogallol-O-sulfate PGS 205 125 + + 
methylpryogallol-O-sulfate MPGS 219 205, 125 + + 
catechol-O-sulfate CS 189 109 + + 
1. Trace, indicated metabolite was detected but was below the lower limit of quantification, a signal to noise ratio of 5 to 1. 
2. ND, metabolite was not detected. 
3. +, indicates metabolite was quantified.  
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Five of the seven metabolites, 4-O-methylgallic acid-3-O-sulfate, pyrogallol-O-
sulfate, catechol-O-sulfate, and two isomers of methylpyrogallol-O-sulfate (I and II) 
were above the lower limit of quantification, a signal to noise ratio of 5 to 1, and were 
measured in the urine up to 24 h post-prandial. Gallic acid and 4-O-methylgallic acid 
were detected in the urine of subjects however they were below the lower limit of 
quantification. In the Lean cohort, a significant (p<0.05) increase was found in the 
excretion of all quantifiable metabolites (Figure 21). Specifically, the cumulative 24 h 
excretion of 4-O-methylgallic acid-3-O-sulfate increased from 10.6 ± 2.38 to 36.13 ± 
5.53 mg, pyrogallol-O-sulfate from 14.3 ± 1.50 to 57.8 ± 5.37 mg, methylpyrogallol-O-
sulfate I from 8.58 ± 1.16 to 40.3 ± 9.51 mg, methylpyrogallol-O-sulfate II from 8.40 ± 
1.43 to 50.3 ± 8.00, and catechol-O-sulfate from 21.7 ± 2.90 to 96.3 ± 12.8 mg between 
Days 1 and 42 respectively. The same increase in 24 h urinary excretion was observed in 
the Obese cohort for all quantifiable metabolites except methylpyrogallol-O-sulfate I, 
which was found to have an insignificant increase from 22.1 ± 5.70 to 45.7 ± 11.1. In the 
Control cohort, no difference in urinary excretion was observed for the galloyl 
metabolites with the exception of methylpyrogallol-O-sulfate I, which was less excreted 
at Day 42 compared to Day 1 (Figure 21; p< 0.05). 
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Figure 21. The sum of urinary excretion in mg for the metabolites 4-O-methylgallic 
acid-3-O-sulfate (MGS), pyrogallol-O-sulfate (PGS), two isomers of methylpyrogallol-
O-sulfate (MPGS), and catechol-O-sulfate (CS) after consumption of 400 g of mango cv. 
Ataulfo for Days 1 and 42 in the (A) Lean and (C) Obese Cohorts who consumed mango 
daily for 42 days and the (B) Control Cohort who consumed mango only on Days 1 and 
42. A (*) designates a significant difference between Days 1 and 42 for the respective 
metabolite. 
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The increase in galloyl metabolism and excretion has been hypothesized to be 
due to changes in the composition of the subjects’ gut microbiota. It has previously been 
demonstrated that repetitive polyphenolic intake will affect the composition of a hosts’ 
gut microbiota such as an increase in the population sizes of the probiotic bacteria 
species of Bifidobacterium and Lactobacillus [168-170]. Corresponding work has shown 
that changes in the gut microbiota can also result in increases in polyphenol metabolism. 
Pereira-Caro et al. (2013) observed an increase in the bioavailability, assessed by 24 h 
urinary excretion, of orange juice polyphenols with an increase from 22% of the initial 
dose (196 µmol) to 70% in subjects who consumed a Bifidobacterium longum probiotic 
daily for 4 wks [171]. On Day 1 of this study, total urinary excretion of all galloyl 
metabolites corresponded to 24.3% of the 259 mg of galloyl derivatives consumed in the 
lean cohort and 45.2% in the obese cohort. Gallotannins are poorly absorbed from the 
small intestine in comparison to lower molecular weight polyphenolic such as gallic 
acid, and are hypothesized to transit to the colon and be hydrolyzed by the microbiota to 
create gallic acid, pyrogallol, and catechol by organisms such as Lactobacillus 
plantarum and Streptococcus galloylitcus [115, 172]. We hypothesized that on Day 1 the 
subjects would not be fully adept at gallotannin hydrolysis, but over time microbiota 
selectively acclimated to utilize gallotannins as an energy source and produced higher 
concentrations of absorbable galloyl metabolites. The significant increases in total 
urinary excretion in the Lean and Obese cohorts from Day 1 to Day 42 support the 
hypothesis as the 24 h urinary excretion of galloyl derivatives increased to 107 and 
130% of the dose of galloyl derivatives fed. 
 98 
 
On both Days 1 and 42, pyrogallol-O-sulfate, methylpyrogallol-O-sulfate I, 
methylpyrogallol-O-sulfate II, and catechol-O-sulfate were still being produced and 
excreted 24 h post-prandial and on Day 42 were found in the baseline urine of subjects 
in the Lean and Obese cohorts (Figure 22). The prolonged generation of pyrogallol 
metabolites has previously been reported, and they have been observed to be absorbed 
and metabolized up to 48 h after a single serving of grape seed or black tea extract [84, 
173]. Bowel transit times vary significantly based on factors such as age, race, and diet, 
and can range in time from 6 to 42 h [174, 175]. Due to the time range that mango could 
have resided in the colon it is possible that some of the metabolites excreted in the urine 
of the Lean and Obese on Day 42 were sourced from the mango consumed from a 
previous days intake. The increase in excretion to 107 and 130% of the 259 mg of 
galloyl derivatives consumed for the Lean and Obese cohorts, respectively, supports this 
hypothesis, and ultimately we can’t conclude how much of the increase was due to 
changes in bacteria populations or if it came from the mango consumed from previous 
dosages. 
 
6.3.2 Plasma Pharmacokinetics Following 42 Days of Daily Mango Consumption 
Five phase II galloyl metabolites, 4-O-methylgallic acid, 4-O-methylgallic acid-
3-O-sulfate, pyrogallol-O-sulfate, methylpyrogallol-O-sulfate, and catechol-O-sulfate, 
were characterized and semi-quantified in plasma up to 8 h post-prandial following 
consumption of Ataulfo mango (Table 9). Extraction of metabolites from plasma was  
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Figure 22. Cumulative excretion in mg of the galloyl metabolites: 4-O-methylgallic acid-3-O-sulfate (MGS), pyrogallol-O-
sulfate (PGS), two isomers of methylpyrogallol-O-sulfate (MPGS), and catechol-O-sulfate (CS) in the Lean Cohort following 
daily consumption of 400 g of mango cv. Ataulfo for 42 days on Days 1 and 42. 
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evaluated against an internal standard ethyl gallate whose average recovery was 94.1 ± 
0.54% across the three cohorts. In contrast to the higher urinary excretion observed in 
the Lean and Obese cohorts after 42 days of consuming 400 g of mango no significant 
increase was observed based on the AUC0-8h for individual plasma metabolites (Table 
10). However, a trend of insignificant increases was observed for all individual 
metabolites in the Lean cohort along with non-significant increases for catechol-O-
sulfate and 4-O-methylgallic acid sulfate in the Obese cohort where high coefficients of 
variation between subjects ranging from 32 – 118% kept comparisons from being 
significant. High coefficients of variation are frequently reported for polyphenolic 
metabolomics investigations, and are hypothesized to be due to differences in gut 
microbiota compositions per subject [176]. The Control cohort was also found to have 
no significant differences in the plasma concentrations of gallic acid metabolites on 
Days 1 and 42. In contrast, the sum of the AUC0-8h for all galloyl metabolites 
concentrations revealed a significant increase for Lean and Obese cohorts between Days 
1 and 42 with total AUC0-8h of 20,400 ± 1,610 to 29,400 ± 2,520 μg/L·h and 13,900 ± 
1,010 to 17,400 ± 989 μg/L·h, for the Lean and Obese cohorts respectively (Figure 23). 
An insignificant decrease was observed for the Control cohort with total AUC0-8h of 
24,100 ± 2,670 to 18,010 ± 1,793 μg/L·h. Despite the obese cohort excreting 130% of 
the initial galloyl derivatives dose on Day 42 when the total AUC0-8h were compared 
against each other the Lean cohort was significantly higher than the Control and Obese 
cohorts (ANOVA; p<0.05).  
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Table 10. Area Under the Curve (AUC) from 0 to 8 h of phase II metabolites sourced from gallic acid and galloyl glycosides 
following daily consumption of mango cv. Ataulfo pulp for 42 days in Lean and Obese Cohorts, and compared against subjects 
who consumed mango only on days 1 and 42, Control Cohort.  
 Control Cohort 
AUC0-8h (μg/L · h) 
Lean Cohort 
AUC0-8h (μg/L · h) 
Obese Cohort 
 AUC0-8h (μg/L · h) 
Metabolite Day 1 Day 42 Day 1 Day 42 Day 1 Day 42 
4-O-methylgallic acid 527 ± 
108 
515 ± 
300 
431 ± 
233 
1,430 ± 
760 
585 ± 
227 
504 ± 
96.3 
4-O-methylgallic acid-3-
O-sulfate 
4,440 ± 
1,140 
5,110 ± 
1,450 
3,390 ± 
487 
4,410 ± 
728 
1,120 ± 
299 
1,729 ± 
457 
pyrogallol-O-sulfate 5,010 ± 
1,580 
2,290 ± 
317 
5,120 ± 
1,430 
6,830 ± 
1,880 
1,380 ± 
496 
1,010 ± 
397 
methylpyrogallol-O-
sulfate 
4,680 ± 
1,380 
2,303 ± 
298 
2,710 ± 
562 
4,920 ± 
1,260 
3,550 ± 
894 
3,440 ± 
1,130 
catechol-O-sulfate 9,420 ± 
3,350 
7,790 ± 
2,200 
8,790 ± 
1,920 
11,800 ± 
3,060 
7,318 ± 
1,980 
10,720 
± 1,790 
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Figure 23. Sum of the area under the curve (AUC) for all galloyl metabolites in the 
plasma of subjects who consumed mango only on Days 1 and 42 (Control) and those 
who consumed mango daily for 42 days, on Days 1 and 42 (Lean and Obese). A (*) 
designates a significant difference between Days 1 and 42 for the respective cohort. 
 
 
 
As well when individual metabolites were compared against each other the Lean cohort 
was significantly higher in the AUC0-8h of 4-O-methylgallic acid-3-O-sulfate and 
pyrogallol-O-sulfate. Studies are lacking which compare the pharmacokinetics of 
polyphenolics in different populations though in one study which compared the tissue 
distribution of catechin in Lean and Obese rats the Lean rats had higher adipose tissue 
concentrations of catechin and its phase II metabolites methylcatechin-glucuronide 
[177]. Thus, while significant differences were not found for individual metabolite 
plasma concentrations in the Lean and Obese cohorts, a significant increase was 
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observed for the sum of all metabolites with the Lean cohort having a significantly 
higher total AUC0-8h on Day 42 compared to the other cohorts. 
Similar observations were made when a grape and blueberry polyphenolic extract 
fed at a dose of 3.5 mg gallic acid / kg body weight to rats for 15 days produced no 
significant difference for gallic acid concentrations in plasma [178]. Likewise, it was 
reported that daily administration of grape seed extract dosed at 3.1 mg of gallic acid /  
kg of body weight to rats had no significant effect on the concentration of gallic acid 
metabolites in brain, liver, or heart tissues [177]. The lack of meaningful accumulation 
of gallic acid on its metabolites in blood observed both in this study and in others is 
likely the result of their rapid metabolism and excretion. Our prior work in a porcine 
model as discussed in Chapter IV found the half-life of gallic acid was 6 min, 
considerably shorter than other polyphenolics such as epigallocatechin gallate 
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Figure 24. Plasma concentrations of 4-O-methylgallic acid-3-O-sulfate in human plasma 
on Days 1 and 42 following consumption of 400 g of mango (cv. Ataulfo) pulp in the 
Lean Cohort who consumed mango daily for 42 days. A (*) designates a significant 
difference between Days 1 and 42. 
 
 
 
which was found in have a half-life of 51 min in rats indicating a rapid metabolic turn-
over of free gallic acid and mono-galloylglucose present in mango [143]. In contrast, 
when 50, 100, 150 mg quercetin supplements were administered daily for two weeks a 
significant difference in plasma concentrations was observed across all three dosing 
regiments up to 24 h post prandial. It is possible that the 8 h post-prandial blood 
collection used in this study was not long enough to observe the significant changes 
found in the 24 h urinary excretion. As an example, in the Lean cohort 4-O-methylgallic 
acid-3-O-sulfate was found to have a significantly higher concentration at 8 h on Day 42 
when compared to Day 1 (Figure 24). Ultimately, Del Rio et al. (2012) concluded that 
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the characterization and quantification of polyphenol metabolites in blood is an 
inadequate measurement of bioavailability and rather the cumulative urinary excretion is 
likely more accurate for mass balance calculations since any absorbed polyphenols will 
ultimately be excreted [179]. Observations from this study support this hypothesis as 
plasma concentrations from 8 h post-prandial did not experience the same increase as 
observed in urine in the same time range. 
It is unknown exactly how rapid excretion of these metabolites affects the 
potential health benefits from consumption of gallic acid glycosides and gallotannins. 
Though studies which have investigated the bioefficacy of habitual consumption of pro-
gallic acid and pro-pyrogallol foods such as strawberries, raspberries, grapes, and tea 
have reported benefits such as reduction in pro-inflammatory biomarkers, however the 
exact mechanisms remain unknown [180-182]. However, results from this study and 
others suggest that galloyl metabolites are rapidly eliminated from the body indicating 
they will likely have short incubation times in tissues. For galloyl derivatives it is 
possible that their health benefits are not tied to their systemic concentrations, but 
through their influence on cell signaling mechanisms [183]. In order to fully understand 
mechanisms of action future work needs to be performed with polyphenol phase II 
metabolites at the sites of action or investigate if their bioactivity is linked to regulation 
of our systemic anti-oxidant and anti-inflammatory pathways. 
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6.4 Conclusions 
The urinary excretion and plasma concentrations of phase II metabolites sourced 
from mango gallic acid, galloyl glycosides, and gallotannins was assessed in lean and 
obese subjects who consumed mango daily for 42 days, and compared against subjects 
who consumed mango only on Days 1 and 42. In the Lean and Obese cohorts, significant 
increases were found in the cumulative 24 h urinary excretion of 4-O-methylgallic acid-
3-O-sulfate, methylpyrogallol-O-sulfate, pyrogallol-O-sulfate, and catechol-O-sulfate 
and were hypothesized to be due to adaptations in the subjects gut microflora. No 
significant differences were found in the individual plasma concentrations of these 
metabolites up to 8 h post-prandial. It was hypothesized that the galloyl and pyrogallol 
metabolites are rapidly excreted and will not accumulate in plasma. Studies investigating 
the mechanisms of action for galloyl phase II metabolites need to be performed to see if 
their bioefficacy is limited to a specific site of action or through regulation of cell 
signaling pathways. 
 107 
 
CHAPTER VII 
SUMMARY AND CONCLUSIONS 
 
The pulp of Ataulfo, Tommy Atkins, Keitt, Haden, and Kent mango cultivars 
were investigated for their galloyl derivative content. Ataulfo had the highest among all 
cultivars with 21.6 ± 4.53 mg/kg of gallic acid, 189 ± 2.09 mg/kg of ester-monogalloyl 
glucose, and 3,040 ± 962 mg/kg of gallotannins while Kent had the lowest with 41.3 ± 
0.68 of gallic acid, 41.3 ± 2.6 mg/kg of ester-monogalloyl glucose, 127 ± 30 mg/kg and 
of gallotannins. Additionally, the enzymatic hydrolysis of gallotannins with tannase was 
evaluated and the intermediates characterized, and when pentagalloyl glucose was 
hydrolyzed two tetragalloyl glucoses, six trigalloyl glucoses, and five digalloyl glucoses 
were characterized each hypothesized to have unique stereochemistry and as a result a 
unique bioavailability. Galloyl glycosides and other gallated species are found in many 
foods stuffs and have the potential to affect the diet of a large percent of the global 
population.  
The polyphenol composition of mango pulp is comprised primarily of galloyl 
derivatives. In this study, the galloyl derivatives monogalloyl glucose and gallic acid 
were found to be bioaccessible in both homogenized and cubed mango pulp and have the 
potential to be absorbed and metabolized. A significant amount of gallotannins remained 
bound within the food matrix for both homogenized and cubed mango suggesting 
limited bioaccessibility in the small intestine and will transit to the colon. For the first 
time gallic acid and monogalloyl glucose were shown to be transported across Caco-2 
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monolayers at a similar rate. In a porcine model, similar amounts of phase II galloyl 
metabolites were found for gallic acid and monogalloyl glucose following oral 
administration, and this may suggest that the differences in composition of non-tannin 
galloyl derivatives between mango cultivars is not a major factor impacting the 
physiological production of gallic acid metabolites. 
  In conclusion, a novel protein precipitation method utilizing SDS was developed 
for improved recovery of gallic acid from human plasma. The SDS denaturation protocol 
was utilized to extract human plasma for gallic acid metabolites generated after an acute 
feeding of 400 g of fresh mango pulp. Five metabolites, two from gallic acid and three 
from pyrogallol were characterized and semi-quantified over an 8 h period. The SDS 
method was proven to be able to extract significantly more gallic acid metabolites from 
plasma compared to current methods reported in the literature. Plasma extraction of 
gallic acid and its metabolites with SDS is a simple and rapid method that has the 
potential to be applied in the analysis of other polyphenolic analytes. 
The urinary excretion and plasma concentrations of phase II metabolites sourced 
from mango gallic acid, galloyl glycosides, and gallotannins was assessed in lean and 
obese subjects who consumed mango daily for 42 days, and compared against subjects 
who consumed mango only on Days 1 and 42. In the Lean and Obese cohorts, significant 
increases were found in the cumulative 24 h urinary excretion of 4-O-methylgallic acid-
3-O-sulfate, methylpyrogallol-O-sulfate, pyrogallol-O-sulfate, and catechol-O-sulfate 
and were hypothesized to be due to adaptations in the subjects gut microflora. No 
significant differences were found in the individual plasma concentrations of these 
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metabolites up to 8 h post-prandial. It was hypothesized that the galloyl and pyrogallol 
metabolites are rapidly excreted and will not accumulate in plasma. Studies investigating 
the mechanisms of action for galloyl phase II metabolites need to be performed to see if 
their bioefficacy is limited to a specific site of action or through regulation of cell 
signaling pathways. 
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APPENDIX  
 
Plasma Extraction of Gallic Acid 
Additional methods to extract the standards gallic acid, 4-O-methylgallic acid, 
and ethyl gallate from plasma were evaluated besides the three described in Chapter V.  
The solvent ethyl acetate was investigated for its ability to partition polyphenolics from 
plasma. Extraction with ethyl acetate led to poor recovery of standards from plasma 
likely due to the aforementioned affinities between galloyl phenolics and plasma 
proteins. Trichloroacetic acid was additionally tested as a potential extraction aide. It 
was able to denature plasma proteins, however, it too strongly affected the ionization of 
the ESI source and led to poor ionization of analytes. Lastly, a cationic surfactant, cetyl 
trimethylammonium bromide (CTAB), was also investigated, however, CTAB lacked 
the ability to precipitate plasma proteins in acidic pH conditions, and was judged to be 
not applicable for extraction of polyphenol metabolites.  The three methods outlined here 
produced poor recovery of gallic acid and where not further investigated for the 
extraction of galloyl metabolites following consumption of mango. 
 
 
